In IN O
our PRP$ O
studies NNS O
, , O
we PRP O
utilized VBD O
HIV NNP O
- : O
1 CD O
HXB2 NNP B-Gene
and CC O
HIV NNP O
- : O
1 CD O
Z2Z6 NNP B-Gene
core NN I-Gene
enhancers NNS I-Gene
because IN O
the DT O
Z2Z6 NNP B-Gene
strain NN O
has VBZ O
a DT O
single JJ O
point NN O
mutation NN O
flanking VBG O
the DT O
right JJ O
ETS NNP B-Gene
- : I-Gene
binding NN I-Gene
site NN I-Gene
. . O

Precipitation NN O
using VBG O
GST NNP B-Gene
fusion NN I-Gene
proteins NNS I-Gene
containing VBG O
Fyn NNP B-Gene
SH2 NNP B-Gene
, , O
SH3 NNP B-Gene
, , O
and CC O
SH2 NNP B-Gene
/ NNP O
SH3 NNP B-Gene
domains VBZ O
revealed VBD O
that IN O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
bound NN O
principally RB O
to TO O
the DT O
SH3 NNP B-Gene
domain NN I-Gene
of IN O
Fyn NNP B-Gene
. . O

The DT O
most RBS O
important JJ O
risk NN O
factors NNS O
are VBP O
: : O
1 CD O
) ) O
genetic JJ O
; : O
2 CD O
) ) O
Epstein NNP O
- : O
Barr NNP O
virus NN O
( ( O
infectious JJ O
mononucleosis NN O
) ) O
; : O
3 CD O
) ) O
congenital NN O
and CC O
acquired VBD O
immunodeficiency NN O
; : O
4 CD O
) ) O
occupational JJ O
exposure NN O
( ( O
the DT O
wood NN O
industry NN O
) ) O
. . O

Similar JJ O
observations NNS O
were VBD O
made VBN O
with IN O
unilateral JJ O
pneumothorax NN O
of IN O
15 CD O
cmH2O NN O
for IN O
30 CD O
min NN O
. . O

The DT O
effect NN O
of IN O
ligustrazine NN O
hydrochloride NN O
( ( O
LTH NNP O
) ) O
on IN O
depressing VBG O
pulmonary JJ O
artery NN O
hypertension NN O
has VBZ O
been VBN O
proved VBN O
in IN O
recent JJ O
studies NNS O
. . O

63 CD O
. . O
3 CD O
micromol JJ O
/ NN O
1 CD O
, , O
p NN O
< VBD O
0 CD O
. . O
1 CD O
) ) O
and CC O
area NN O
under IN O
the DT O
plasma NN O
concentration NN O
- : O
time NN O
curve NN O
extrapolated VBD O
to TO O
infinity VB O
AUC NNP O
9 CD O
( ( O
0 CD O
- : O
infinity NN O
) ) O
( ( O
518 CD O
. . O
7 CD O
vs NN O
. . O

Abrogation NN O
of IN O
p53 NN B-Gene
function NN O
by IN O
E6 NNP B-Gene
resulted VBD O
in IN O
an DT O
increase NN O
in IN O
the DT O
spontaneous JJ O
mutation NN O
frequencies NNS O
at IN O
the DT O
heterozygous JJ O
thymidine NN B-Gene
kinase NN I-Gene
( ( O
TK NNP B-Gene
) ) O
locus NN O
but CC O
not RB O
at IN O
the DT O
hemizygous JJ O
hypoxanthine NN B-Gene
phosphoribosyl NN I-Gene
transferase NN I-Gene
( ( O
HPRT NNP B-Gene
) ) O
locus NN O
. . O

Overexpression NN O
of IN O
BAG NNP B-Gene
- : I-Gene
1 CD I-Gene
also RB O
protected VBD O
certain JJ O
cell NN O
lines NNS O
from IN O
heat NN O
shock NN O
- : O
induced VBN O
cell NN O
death NN O
. . O

A DT O
724 CD O
- : O
bp NN O
segment NN O
of IN O
the DT O
5 CD O
' POS O
- : O
flanking VBG O
region NN O
consisting NN O
of IN O
the DT O
proximal JJ O
E NNP O
- : O
box NN O
flanked VBD O
upstream JJ O
by IN O
a DT O
mammalian JJ O
- : O
specific JJ O
352 CD O
- : O
bp NN O
region NN O
was VBD O
sufficient JJ O
for IN O
maximal JJ O
transcriptional JJ O
activation NN O
in IN O
postconfluent NN O
BC3H1 NNP O
myoblasts NNS O
. . O

Value NNP O
of IN O
the DT O
method NN O
of IN O
passive JJ O
hemagglutination NN O
with IN O
polysaccharide JJ O
C NNP O
in IN O
detecting VBG O
C NNP B-Gene
- : I-Gene
reactive JJ I-Gene
protein NN I-Gene
as IN O
compared VBN O
to TO O
precipitation NN O
in IN O
capillaries NNS O
and CC O
slide NN O
latex JJ O
test NN O
with IN O
anti JJ B-Gene
- : I-Gene
CRP NN I-Gene
serum NN O

The DT O
uncomplicated JJ O
cases NNS O
of IN O
typhoid JJ O
fever NN O
were VBD O
found VBN O
to TO O
have VB O
an DT O
intact JJ O
CMIR NNP O
as IN O
compared VBN O
to TO O
the DT O
complicated VBN O
cases NNS O
. . O

Effects NNS O
of IN O
ionizing VBG O
radiation NN O
in IN O
the DT O
human JJ O
oral JJ O
cavity NN O
and CC O
oropharynx NN O
: : O
results NNS O
of IN O
a DT O
survey NN O
. . O

MEASUREMENTS NNP O
AND CC O
MAIN NNP O
RESULTS NNP O
: : O
Lung NNP O
elastance NN O
( ( O
EL NNP O
) ) O
and CC O
resistance NN O
( ( O
RL NNP O
) ) O
were VBD O
calculated VBN O
from IN O
measurements NNS O
of IN O
airway JJ O
pressure NN O
, , O
esophageal JJ O
pressure NN O
, , O
and CC O
airway RB O
flow NN O
in IN O
five CD O
anesthetized NNS O
, , O
paralyzed JJ O
dogs NNS O
during IN O
sinusoidal JJ O
forcing NN O
at IN O
a DT O
constant JJ O
mean NN O
airway NN O
pressure NN O
of IN O
10 CD O
cmH2O NN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
breathing VBG O
frequencies NNS O
( ( O
0 CD O
. . O
2 CD O
to TO O
1 CD O
. . O
0 CD O
Hz NNP O
in IN O
intervals NNS O
of IN O
0 CD O
. . O
2 CD O
) ) O
and CC O
tidal JJ O
volumes NNS O
( ( O
50 CD O
, , O
100 CD O
, , O
200 CD O
, , O
and CC O
to TO O
300 CD O
mL NN O
) ) O
. . O

Elimination NN O
of IN O
bagassosis NN O
in IN O
Louisiana NNP O
paper NN O
manufacturing NN O
plant NN O
workers NNS O
. . O

The DT O
first JJ O
identification NN O
of IN O
the DT O
active JJ O
37LRP CD B-Gene
/ JJ O
p40 NN B-Gene
gene NN O
presented VBN O
in IN O
this DT O
study NN O
is VBZ O
a DT O
critical JJ O
step NN O
toward IN O
the DT O
isolation NN O
of IN O
the DT O
corresponding JJ O
human JJ O
gene NN O
and CC O
the DT O
understanding NN O
of IN O
the DT O
molecular JJ O
mechanisms NNS O
involved VBN O
in IN O
the DT O
up RP O
- : O
regulation NN O
of IN O
its PRP$ O
expression NN O
during IN O
tumor NN O
invasion NN O
and CC O
metastasis NN O
. . O

Mapping VBG O
results NNS O
suggested VBD O
that IN O
the DT O
complementation NN O
group NN O
identified VBN O
by IN O
these DT O
mutants NNS O
is VBZ O
allelic JJ O
to TO O
the DT O
ag NN B-Gene
alpha VBZ I-Gene
1 CD I-Gene
mutation NN O
identified VBD O
previously RB O
. . O

These DT O
six CD O
amino NN O
acids NNS O
are VBP O
part NN O
of IN O
an DT O
amphipathic JJ O
helix NN O
that WDT O
is VBZ O
highly RB O
conserved VBN O
among IN O
nuclear JJ B-Gene
hormone NN I-Gene
receptors NNS I-Gene
and CC O
contains VBZ O
the DT O
core NN O
domain NN O
of IN O
the DT O
ligand NN O
- : O
dependent JJ O
transactivation NN O
function NN O
, , O
AF NNP O
- : O
2 CD O
. . O

We PRP O
found VBD O
that IN O
both DT O
the DT O
E26 NNP O
virus NN O
- : O
encoded VBD O
v JJ B-Gene
- : I-Gene
ets NNS I-Gene
and CC O
the DT O
myeloid NN B-Gene
/ NN I-Gene
B NNP I-Gene
- : I-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
factor NN I-Gene
PU NNP I-Gene
. . I-Gene
1 CD I-Gene
bind NN O
efficiently RB O
to TO O
this DT O
site NN O
in IN O
vitro NN O
. . O

Additionally RB O
, , O
a DT O
CaCO3 NNP O
- : O
CO2 NNP O
/ NNP O
N2 NNP O
buffered VBD O
solution NN O
was VBD O
necessary JJ O
to TO O
maintain VB O
a DT O
pH NN O
of IN O
8 CD O
. . O

Immunofluorescence NN O
studies NNS O
in IN O
C2C12 NNP O
myotubes NNP O
show VBP O
that IN O
Smad2 NNP B-Gene
and CC O
MEF2A NNP B-Gene
co VBP O
- : O
localise NN O
in IN O
the DT O
nucleus NN O
of IN O
multinuclear JJ O
myotubes NNS O
during IN O
differentiation NN O
. . O

The DT O
DNase NNP B-Gene
I PRP I-Gene
footprint VBP O
extended VBD O
5 CD O
' '' O
in IN O
the DT O
silencer NN O
region NN O
to TO O
include VB O
an DT O
inverted JJ O
repeat NN O
of IN O
a DT O
six CD O
- : O
nucleotide NN O
motif NN O
( ( O
epsilon SYM O
- : O
267 CD O
to TO O
- : O
278 CD O
bp NN O
) ) O
which WDT O
shares NNS O
5 CD O
of IN O
6 CD O
bases NNS O
with IN O
the DT O
GATA NNP B-Gene
- : I-Gene
1 CD I-Gene
consensus NN I-Gene
sequence NN I-Gene
. . O

Polypyrimidine NNP O
and CC O
ssDNA NN O
binding NN O
by IN O
the DT O
isolated JJ O
VH NNP B-Gene
domain NN I-Gene
of IN O
immunization NN O
- : O
induced JJ O
anti IN O
- : O
Z NNP O
- : O
DNA NN O
Ab NNP O
resembles VBZ O
the DT O
activity NN O
of IN O
natural JJ O
autoantibodies NNS O
and CC O
suggests VBZ O
that IN O
VH NNP B-Gene
- : O
dependent NN O
binding NN O
to TO O
a DT O
ligand NN O
mimicked VBN O
by IN O
polypyrimidines NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
B NNP O
cell NN O
selection NN O
before IN O
immunization NN O
with IN O
Z NNP O
- : O
DNA NN O
. . O

Detection NN O
of IN O
poisoning NN O
by IN O
Impila NNP O
( ( O
Callilepis NNP O
laureola NN O
) ) O
in IN O
a DT O
mother NN O
and CC O
child NN O
. . O

A DT O
developmentally RB O
modulated VBN O
chromatin NN O
structure NN O
at IN O
the DT O
mouse NN B-Gene
immunoglobulin NN I-Gene
kappa VBD I-Gene
3 CD I-Gene
' '' I-Gene
enhancer NN I-Gene
. . O

These DT O
corrections NNS O
do VBP O
not RB O
involve VB O
sequences NNS O
predicted VBN O
to TO O
function VB O
as IN O
transcription NN O
factor NN O
binding VBG O
sites NNS O
. . O

Taken VBN O
together RB O
, , O
these DT O
observations NNS O
indicate VBP O
that IN O
the DT O
C NNP O
- : O
terminal JJ O
24 CD O
amino JJ O
acids NNS O
are VBP O
sufficient JJ O
for IN O
NodO NNP B-Gene
secretion NN O
although IN O
the DT O
region NN O
adjacent NN O
to TO O
this DT O
domain NN O
appears VBZ O
to TO O
affect VB O
secretion NN O
efficiency NN O
. . O

The DT O
ability NN O
to TO O
maintain VB O
expression NN O
of IN O
FAS1 NNP B-Gene
in IN O
nmt1 JJ B-Gene
- : O
451Dino2 CD B-Gene
Delta NNP O
cells NNS O
suggests VBZ O
the DT O
existence NN O
of IN O
another DT O
transcription NN O
factor NN O
, , O
or CC O
factors NNS O
, , O
whose WP$ O
expression NN O
/ NN O
activity NN O
is VBZ O
inversely RB O
related VBN O
to TO O
overall JJ O
levels NNS O
of IN O
cellular JJ O
protein NN O
N NNP O
- : O
myristoy NN O
- : O
lation NN O
. . O

Because IN O
the DT O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
sites NNS I-Gene
in IN O
the DT O
hGH NN B-Gene
- : I-Gene
N NNP I-Gene
gene NN I-Gene
promoter NN I-Gene
are VBP O
insufficient JJ O
for IN O
such JJ O
gene NN O
activation NN O
in IN O
vivo NN O
, , O
these DT O
data NNS O
suggested VBD O
a DT O
unique JJ O
chromatin NN O
- : O
mediated VBN O
developmental JJ O
role NN O
for IN O
Pit NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
the DT O
hGH NN B-Gene
LCR NNP I-Gene
. . O

Deletion NNP O
studies NNS O
identified VBD O
a DT O
distal JJ O
response NN O
element NN O
that WDT O
is VBZ O
responsible JJ O
for IN O
the DT O
cytokine NN O
response NN O
and CC O
has VBZ O
properties NNS O
of IN O
an DT O
inducible JJ O
transcriptional JJ O
enhancer NN O
. . O

Mouse NNP B-Gene
growth NN I-Gene
hormone NN I-Gene
transcription NN I-Gene
factor NN I-Gene
Zn NNP I-Gene
- : I-Gene
16 CD I-Gene
: : O
unique JJ O
bipartite NN O
structure NN O
containing VBG O
tandemly RB O
repeated VBN O
zinc NN O
finger NN O
domains VBZ O
not RB O
reported VBN O
in IN O
rat NN B-Gene
Zn NNP I-Gene
- : I-Gene
15 CD I-Gene
. . O

The DT O
presence NN O
of IN O
truncated JJ O
receptor NN O
isoforms NNS O
in IN O
diverse JJ O
species NNS O
suggests VBZ O
that IN O
these DT O
proteins NNS O
may MD O
have VB O
important JJ O
functional JJ O
roles NNS O
in IN O
regulating VBG O
EGFR NNP B-Gene
activity NN O
. . O

With IN O
Sair NNP O
and CC O
So2 NNP O
, , O
mean JJ O
vital JJ O
capacity NN O
was VBD O
reduced VBN O
by IN O
44 CD O
% NN O
from IN O
control NN O
. . O

It PRP O
could MD O
be VB O
detected VBN O
exclusively RB O
in IN O
the DT O
culture NN O
medium NN O
of IN O
cDNA NN O
- : O
transfected VBN O
COS NNP O
cells NNS O
. . O

A DT O
20 CD O
- : O
base NN O
pair NN O
oligonucleotide IN O
containing VBG O
this DT O
nonamer NN O
confers VBZ O
up RP O
- : O
regulation NN O
by IN O
hypoxia NN O
and CC O
inhibition NN O
by IN O
unsaturated JJ O
fatty JJ O
acids NNS O
when WRB O
placed VBN O
upstream NN O
of IN O
a DT O
heterologous JJ O
promoter NN O
in IN O
a DT O
lacZ JJ B-Gene
reporter NN I-Gene
construct NN I-Gene
. . O

The DT O
algorithm NN O
also RB O
limited VBD O
TG NNP O
to TO O
20 CD O
and CC O
64 CD O
% NN O
, , O
apoB NN B-Gene
to TO O
6 CD O
and CC O
20 CD O
% NN O
, , O
and CC O
Lp NNP B-Gene
( ( I-Gene
a DT I-Gene
) ) I-Gene
to TO O
15 CD O
and CC O
56 CD O
% NN O
, , O
of IN O
low JJ O
- : O
and CC O
high JJ O
- : O
risk NN O
groups NNS O
, , O
respectively RB O
. . O

The DT O
patients NNS O
were VBD O
divided VBN O
into IN O
ischaemia NN O
and CC O
non JJ O
- : O
ischaemia NN O
groups NNS O
on IN O
the DT O
basis NN O
of IN O
the DT O
change NN O
in IN O
lactate JJ O
extraction NN O
ratio NN O
during IN O
balloon NN O
inflation NN O
. . O

A DT O
cis NN O
- : O
acting VBG O
DNA NNP O
element NN O
located VBD O
between IN O
TATA NNP O
box NN O
and CC O
transcription NN O
initiation NN O
site NN O
is VBZ O
critical JJ O
in IN O
response NN O
to TO O
regulatory JJ O
sequences NNS O
in IN O
human JJ O
angiotensinogen NN B-Gene
gene NN I-Gene
. . O

A DT O
Golgi NNP O
study NN O
of IN O
the DT O
sixth JJ O
layer NN O
of IN O
the DT O
cerebral JJ O
cortex NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
ATF NNP B-Gene
- : I-Gene
2 CD I-Gene
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
TGF NNP B-Gene
- : I-Gene
beta NN I-Gene
signaling NN O
by IN O
acting VBG O
as IN O
a DT O
common JJ O
nuclear JJ O
target NN O
of IN O
both DT O
Smad NNP B-Gene
and CC O
TAK1 NNP B-Gene
pathways NNS O
. . O

Further RB O
, , O
Ser NNP O
/ NNP O
Thr NNP O
phosphorylation NN O
of IN O
downstream NN O
molecules NNS O
Akt NNP B-Gene
and CC O
p70 VB B-Gene
S6 NNP I-Gene
kinase NN I-Gene
was VBD O
inhibited VBN O
. . O

Two CD O
new JJ O
artifacts NNS O
in IN O
automated JJ O
coagulation NN O
testing NN O
. . O

Pseudomembranous JJ O
conjunctivitis NN O
following VBG O
bone NN O
marrow JJ O
transplantation NN O
: : O
immunopathological JJ O
and CC O
ultrastructural JJ O
study NN O
of IN O
one CD O
case NN O
. . O

To TO O
better RBR O
understand VB O
the DT O
role NN O
of IN O
Ets NNP B-Gene
proteins VBZ I-Gene
in IN O
Ras NNP B-Gene
transformation NN O
, , O
we PRP O
have VBP O
now RB O
analyzed VBN O
the DT O
effects NNS O
of IN O
stably RB O
expressing VBG O
a DT O
variety NN O
of IN O
Ets2 NNP B-Gene
constructs NNS I-Gene
in IN O
Ras NNP B-Gene
- : O
transformed VBD O
NIH3T3 NNP O
( ( O
DT NNP O
) ) O
cells NNS O
. . O

Protein NNP B-Gene
kinase VBD I-Gene
A NNP I-Gene
- : I-Gene
Ialpha NNP I-Gene
subunit SYM O
- : O
directed VBN O
antisense JJ O
inhibition NN O
of IN O
ovarian JJ O
cancer NN O
cell NN O
growth NN O
: : O
crosstalk NN O
with IN O
tyrosine JJ B-Gene
kinase NN I-Gene
signaling VBG O
pathway NN O
. . O

Analysis NN O
of IN O
regulatory JJ O
regions NNS O
in IN O
the DT O
promoter NN O
of IN O
the DT O
ctr4 NN B-Gene
( ( I-Gene
+ NNP I-Gene
) ) I-Gene
copper NN I-Gene
transporter NN I-Gene
gene NN I-Gene
in IN O
fission NN O
yeast NN O
Schizosaccharomyces NNP O
pombe NN O
reveals VBZ O
the DT O
identity NN O
of IN O
a DT O
conserved VBN O
copper NN O
- : O
signaling VBG O
element NN O
( ( O
CuSE NNP O
) ) O
, , O
which WDT O
is VBZ O
recognized VBN O
by IN O
the DT O
transcription NN B-Gene
factor NN I-Gene
Cuf1 NNP I-Gene
. . O

RVR NNP B-Gene
' POS O
loss NN O
of IN O
function NN O
' POS O
studies NNS O
by IN O
constitutive NN O
over IN O
- : O
expression NN O
of IN O
a DT O
dominant JJ O
negative JJ O
RVR NNP B-Gene
delta NN I-Gene
E NNP I-Gene
resulted VBD O
in IN O
increased JJ O
levels NNS O
of IN O
p21Cip1 NN B-Gene
/ NNP O
Waf1 NNP B-Gene
and CC O
myogenin NNP B-Gene
mRNAs NN I-Gene
after IN O
serum NN O
withdrawal NN O
. . O

Conventionally RB O
, , O
four CD O
nominal JJ O
allotypic NN O
variants NNS O
, , O
b4 NN O
, , O
b5 NN O
, , O
b6 NN O
and CC O
b9 NN O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
co JJ O
- : O
dominantly RB O
expressed VBN O
at IN O
the DT O
Ckappa1 NNP B-Gene
gene NN I-Gene
locus NN I-Gene
. . O

Fowlpox NNP O
virus NN O
encodes VBZ O
nonessential JJ O
homologs NNS O
of IN O
cellular JJ B-Gene
alpha SYM I-Gene
- : I-Gene
SNAP NN I-Gene
, , O
PC NNP B-Gene
- : I-Gene
1 CD I-Gene
, , O
and CC O
an DT O
orphan JJ O
human JJ O
homolog NN O
of IN O
a DT O
secreted JJ O
nematode NN O
protein NN O
. . O

1 CD O
( ( O
"""" VB O
long RB O
method JJ O
"""" NN O
) ) O
and CC O
the DT O
HML NNP O
method NN O
. . O

Overexpression NN O
of IN O
wild JJ B-Gene
- : I-Gene
type NN I-Gene
p53 NN I-Gene
also RB O
induces VBZ O
apoptosis NN O
in IN O
an DT O
LCL NNP O
. . O

The DT O
hatcher NN O
incubators NNS O
of IN O
both DT O
companies NNS O
were VBD O
also RB O
persistently RB O
contaminated VBN O
with IN O
Salmonella NNP O
livingstone NN O
and CC O
Salmonella NNP O
thomasville NN O
in IN O
company NN O
A NNP O
and CC O
with IN O
Salmonella NNP O
senftenberg NN O
in IN O
company NN O
B NNP O
. . O

Re NN O
: : O
"""" NN O
Assessing VBG O
the DT O
direction NN O
of IN O
causality NN O
in IN O
cross NN O
- : O
sectional JJ O
studies NNS O
"""" VBP O
. . O

Three CD O
of IN O
the DT O
short JJ O
ORFs NNP O
in IN O
the DT O
central JJ O
region NN O
of IN O
BIV NNP O
have VBP O
been VBN O
identified VBN O
by IN O
location NN O
and CC O
structural JJ O
similarity NN O
to TO O
the DT O
nonstructural JJ O
/ NNP O
regulatory JJ O
genes NNS O
( ( O
vif NN B-Gene
, , O
tat NN B-Gene
, , O
and CC O
rev NN B-Gene
) ) O
of IN O
other JJ O
lentiviruses NNS O
; : O
we PRP O
also RB O
discovered VBD O
two CD O
unique JJ O
ORFs NNP O
, , O
termed VBD O
W NNP O
and CC O
Y NNP O
, , O
which WDT O
may MD O
serve VB O
as IN O
exons NNS O
for IN O
novel JJ O
genes NNS O
. . O

The DT O
original JJ O
technique NN O
was VBD O
developed VBN O
in IN O
the DT O
1960 CD O
' POS O
s NN O
to TO O
analyze VB O
the DT O
inner JJ O
ear JJ O
fluid NN O
as IN O
a DT O
diagnostic JJ O
procedure NN O
( ( O
i JJ O
. . O
e NN O
. . O
, , O
diagnostic JJ O
labyrinthotomy NN O
) ) O
in IN O
acoustic JJ O
neuroma NN O
suspects NNS O
. . O

CONCLUSION NN O
: : O
The DT O
presence NN O
of IN O
known VBN O
autoimmune JJ O
disease NN O
in IN O
a DT O
woman NN O
with IN O
POF NNP O
should MD O
not RB O
dissuade VB O
the DT O
clinician NN O
from IN O
evaluating VBG O
for IN O
a DT O
potential JJ O
genetic JJ O
cause NN O
. . O

The DT O
poly NN O
( ( O
A DT O
) ) O
segment NN O
of IN O
the DT O
RNA NNP O
was VBD O
selectively RB O
cross JJ O
- : O
linked VBN O
to TO O
the DT O
72 CD O
, , O
0 CD O
- : O
molecular JJ O
- : O
weight NN O
protein NN O
( ( O
72K CD O
protein NN O
) ) O
. . O

Subjects NNS O
with IN O
a DT O
short JJ O
postexposure NN O
time NN O
and CC O
a DT O
dioxin NN O
burden NN O
> $ O
0 CD O
. . O
6 CD O
pg JJ O
/ NNP O
m3 NN O
had VBD O
a DT O
significantly RB O
higher JJR O
risk NN O
of IN O
hypoergy NN O
than IN O
unexposed JJ O
subjects NNS O
( ( O
hypoergy NN O
I PRP O
: : O
OR CC O
= VB O
9 CD O
. . O
51 CD O
, , O
95 CD O
% NN O
CI NNP O
= NNP O
1 CD O
. . O
96 CD O
- : O
42 CD O
. . O
2 CD O
; : O
hypoergy JJ O
II NNP O
: : O
OR NNP O
= VBZ O
2 CD O
. . O
92 CD O
, , O
95 CD O
% NN O
CI NNP O
= NNP O
1 CD O
. . O
14 CD O
- : O
7 CD O
. . O
5 CD O
) ) O
. . O

Mapping NN O
of IN O
intracellular JJ O
localization NN O
domains NNS O
and CC O
evidence NN O
for IN O
colocalization NN O
interactions NNS O
between IN O
the DT O
IE110 NNP B-Gene
and CC O
IE175 NNP B-Gene
nuclear JJ O
transactivator NN O
proteins NNS O
of IN O
herpes NNS O
simplex JJ O
virus NN O
. . O

We PRP O
used VBD O
stored VBN O
plasma JJ O
samples NNS O
from IN O
409 CD O
patients NNS O
in IN O
the DT O
National NNP O
Institute NNP O
of IN O
Neurological NNP O
Diseases NNP O
and CC O
Stroke NNP O
( ( O
NINDS NNP O
) ) O
tissue NN B-Gene
plasminogen NN I-Gene
activator NN I-Gene
( ( O
t JJ B-Gene
- : I-Gene
PA NN I-Gene
) ) O
Stroke VBD O
Trial NNP O
to TO O
examine VB O
the DT O
relationship NN O
between IN O
an DT O
apolipoprotein NN B-Gene
( ( I-Gene
Apo NNP I-Gene
) ) I-Gene
E2 NNP I-Gene
or CC O
an DT O
Apo NNP B-Gene
E4 NNP I-Gene
phenotype NN O
and CC O
a DT O
favorable JJ O
outcome NN O
3 CD O
months NNS O
after IN O
stroke NN O
, , O
the DT O
risk NN O
of IN O
intracerebral JJ O
hemorrhage NN O
, , O
and CC O
the DT O
response NN O
to TO O
intravenous JJ O
t SYM B-Gene
- : I-Gene
PA NNP I-Gene
therapy NN O
. . O

These DT O
mutations NNS O
create VBP O
stop JJ O
codons NNS O
in IN O
exon JJ O
7 CD O
and CC O
8 CD O
, , O
respectively RB O
, , O
and CC O
probably RB O
result NN O
in IN O
truncated JJ O
proteins NNS O
lacking VBG O
HLH NNP O
- : O
Zip NN O
or CC O
Zip NNP O
structure NN O
. . O

Vasoactive JJ B-Gene
intestinal JJ I-Gene
peptide NN I-Gene
and CC O
pituitary JJ B-Gene
adenylate NN I-Gene
cyclase NN I-Gene
- : I-Gene
activating VBG I-Gene
polypeptide JJ I-Gene
inhibit NN O
nuclear JJ B-Gene
factor NN I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
- : I-Gene
dependent JJ I-Gene
gene NN I-Gene
activation NN O
at IN O
multiple JJ O
levels NNS O
in IN O
the DT O
human JJ O
monocytic JJ O
cell NN O
line NN O
THP NNP O
- : O
1 CD O
. . O

Perfusion NN O
technique NN O
for IN O
perfusion NN O
- : O
assisted VBN O
direct JJ O
coronary JJ O
artery NN O
bypass NN O
( ( O
PADCAB NNP O
) ) O
. . O

Because IN O
the DT O
human JJ B-Gene
Antp NNP I-Gene
TATAA NNP I-Gene
binding VBG I-Gene
protein NN I-Gene
is VBZ O
expressed VBN O
in IN O
both DT O
lymphoid JJ O
and CC O
non JJ O
- : O
lymphoid NN O
cells NNS O
, , O
we PRP O
suggest VBP O
that IN O
this DT O
homeobox NN B-Gene
gene NN I-Gene
has VBZ O
evolved VBN O
a DT O
more RBR O
general JJ O
transcriptional JJ O
regulatory JJ O
function NN O
in IN O
higher JJR O
eukaryotic JJ O
cells NNS O
. . O

40 CD O
, , O
0 CD O
) ) O
. . O

The DT O
total JJ O
number NN O
of IN O
specimens NNS O
was VBD O
131 CD O
with IN O
78 CD O
nonsmokers NNS O
and CC O
53 CD O
smokers NNS O
. . O

The DT O
3 CD O
. . O
3 CD O
- : O
fold NN O
higher JJR O
expression NN O
in IN O
the DT O
fetal JJ O
heart NN O
than IN O
in IN O
the DT O
adult NN O
heart NN O
suggests VBZ O
that IN O
HFHZ NNP B-Gene
mRNA NN I-Gene
is VBZ O
downregulated VBN O
in IN O
the DT O
process NN O
of IN O
development NN O
. . O

Copyright JJ O
2001 CD O
S NNP O
. . O

The DT O
present JJ O
investigation NN O
conducted VBN O
in IN O
a DT O
population NN O
of IN O
258 CD O
dentally RB O
aware JJ O
individuals NNS O
in IN O
the DT O
age NN O
range NN O
20 CD O
- : O
69 CD O
years NNS O
, , O
was VBD O
initiated VBN O
to TO O
elucidate VB O
the DT O
relationship NN O
between IN O
tobacco NN O
smoking NN O
and CC O
supragingival NN O
calculus NN O
, , O
taking VBG O
into IN O
account NN O
possible JJ O
confounding VBG O
factors NNS O
such JJ O
as IN O
age NN O
, , O
gender NN O
, , O
oral JJ O
hygiene NN O
and CC O
gingival JJ O
inflammation NN O
. . O

SELECTION NNP O
CRITERIA NNP O
: : O
All DT O
controlled VBN O
trials NNS O
where WRB O
adults NNS O
with IN O
schizophrenia NN O
or CC O
similar JJ O
illnesses NNS O
were VBD O
randomised VBN O
to TO O
quetiapine VB O
, , O
placebo NN O
or CC O
other JJ O
neuroleptic JJ O
drugs NNS O
and CC O
where WRB O
clinically RB O
relevant JJ O
outcomes NNS O
were VBD O
reported VBN O
. . O

( ( O
ii NN O
) ) O
An DT O
AF NNP O
G NNP B-Gene
- : I-Gene
CSF NNP I-Gene
level NN O
> NN O
2000 CD O
pg NN O
/ NNP O
ml NN O
is VBZ O
a DT O
strong JJ O
positive JJ O
predictor NN O
of IN O
CAM NNP O
. . O

Exposure NN O
of IN O
peripheral JJ O
blood NN O
T NNP O
cells NNS O
from IN O
young JJ O
subjects NNS O
to TO O
PHA NNP B-Gene
or CC O
cross VB O
- : O
linked VBN O
anti IN B-Gene
- : I-Gene
CD3 NNP I-Gene
monoclonal JJ I-Gene
antibodies NNS I-Gene
stimulated VBD O
rapid JJ O
increases NNS O
in IN O
MAPK NNP B-Gene
and CC O
MEK NNP B-Gene
enzymatic JJ O
activity NN O
. . O

A DT O
note NN O
on IN O
some DT O
consequences NNS O
of IN O
UV NNP O
vision NN O
in IN O
birds NNS O
. . O

We PRP O
demonstrate VBP O
that IN O
Ddc1p NNP B-Gene
interacts VBZ O
physically RB O
in IN O
vivo NN O
with IN O
Mec3p NNP B-Gene
, , O
and CC O
this DT O
interaction NN O
requires VBZ O
Rad17p NNP B-Gene
. . O

Finger NNP B-Gene
associated VBD I-Gene
box SYM I-Gene
- : I-Gene
zinc NN I-Gene
finger NN I-Gene
proteins NNS I-Gene
( ( O
FAX NNP B-Gene
- : I-Gene
ZFPs NN I-Gene
) ) O
constitute VBZ O
a DT O
subfamily NN O
of IN O
the DT O
many JJ O
C2H2 NNP B-Gene
type NN I-Gene
ZFPs NNP I-Gene
in IN O
Xenopus NNP O
laevis NN O
. . O

Mitochondrial JJ B-Gene
Mas70p NNP I-Gene
signal NN I-Gene
anchor NN I-Gene
sequence NN I-Gene
. . O

An DT O
amino NN O
- : O
acid JJ O
sequence NN O
comparison NN O
revealed VBD O
that IN O
Bacillus NNP B-Gene
YM55 NNP I-Gene
- : I-Gene
1 CD I-Gene
aspartase NN I-Gene
shared VBD O
71 CD O
% NN O
homology NN O
with IN O
Bacillus NNP B-Gene
subtilis NNS I-Gene
aspartase NN I-Gene
and CC O
49 CD O
% NN O
with IN O
Escherichia NNP O
coli NNS O
and CC O
Pseudomonas NNP B-Gene
fluorescens VBZ I-Gene
aspartases NNS I-Gene
. . O

RT NNP O
- : O
PCR NN O
analysis NN O
showed VBD O
that IN O
PLP NNP B-Gene
- : I-Gene
H NN I-Gene
as RB O
well RB O
as IN O
PLP NNP B-Gene
- : I-Gene
C NNP I-Gene
and CC O
PLP NNP B-Gene
- : I-Gene
D NNP I-Gene
are VBP O
expressed VBN O
in IN O
all DT O
rat NN O
strains NNS O
examined VBN O
, , O
confirming VBG O
that IN O
PLP NNP B-Gene
diversity NN O
is VBZ O
not RB O
due JJ O
to TO O
strain VB O
differences NNS O
. . O

The DT O
effects NNS O
on IN O
reflex JJ O
latencies NNS O
but CC O
not RB O
on IN O
paCO2 NN O
or CC O
pHa NN O
were VBD O
blocked VBN O
by IN O
naloxone NN O
( ( O
2 CD O
mg NN O
/ NNP O
kg NN O
) ) O
, , O
and CC O
were VBD O
not RB O
present JJ O
in IN O
morphine JJ O
- : O
tolerant NN O
animals NNS O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
the DT O
total JJ O
number NN O
of IN O
subunit JJ O
c NN O
in IN O
F0 NNP B-Gene
should MD O
be VB O
a DT O
multiple NN O
of IN O
2 CD O
and CC O
3 CD O
. . O

The DT O
calcium NN O
requirement NN O
for IN O
hypothermic JJ O
storage NN O
of IN O
the DT O
cardiac JJ O
explant NN O
. . O

The DT O
BRCA1 NNP O
or CC O
BRCA2 NNP O
status NN O
of IN O
four CD O
families NNS O
( ( O
17 CD O
% NN O
) ) O
could MD O
not RB O
be VB O
determined VBN O
. . O

Partial JJ O
sequences NNS O
of IN O
the DT O
1A1 CD O
- : O
3B CD O
B NNP O
- : O
box NN O
protein NN O
pseudogene NN O
and CC O
IFP NNP O
35 CD O
, , O
an DT O
interferon NN O
induced VBD O
leucine JJ O
zipper NN O
protein NN O
, , O
reside VB O
within IN O
the DT O
contig NN O
. . O

By IN O
using VBG O
this DT O
approach NN O
, , O
we PRP O
were VBD O
able JJ O
to TO O
identify VB O
mutation NN O
in IN O
22 CD O
new JJ O
patients NNS O
, , O
but CC O
the DT O
overall JJ O
efficiency NN O
of IN O
the DT O
procedure NN O
when WRB O
we PRP O
used VBD O
a DT O
single JJ O
- : O
pass NN O
regimen NN O
was VBD O
only RB O
48 CD O
% NN O
. . O

The DT O
product NN O
of IN O
the DT O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
gene NN O
( ( O
ATM NNP O
) ) O
was VBD O
identified VBN O
by IN O
using VBG O
an DT O
antiserum NN O
developed VBD O
to TO O
a DT O
peptide NN O
corresponding VBG O
to TO O
the DT O
deduced VBN O
amino NN O
acid NN O
sequence NN O
. . O

Mutations NNS O
in IN O
BRCA1 NNP O
account NN O
for IN O
approximately RB O
45 CD O
% NN O
of IN O
familial JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
and CC O
90 CD O
% NN O
of IN O
inherited JJ B-Disease
breast NN I-Disease
/ JJ I-Disease
ovarian JJ I-Disease
cancer NN I-Disease
, , O
whereas JJ O
mutations NNS O
in IN O
BRCA2 NNP O
account NN O
for IN O
a DT O
comparable JJ O
percentage NN O
of IN O
inherited JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
cases NNS O
. . O

Thus RB O
, , O
we PRP O
screened VBD O
16 CD O
endometrial JJ B-Disease
carcinomas NN I-Disease
with IN O
microsatellite JJ O
instability NN O
for IN O
alterations NNS O
in IN O
FEN1 NNP O
( ( O
the DT O
human JJ O
homolog NN O
of IN O
RTH NNP O
) ) O
and CC O
in IN O
MSH3 NNP O
( ( O
refs VB O
12 CD O
- : O
14 CD O
) ) O
. . O

By IN O
analysis NN O
of IN O
these DT O
compiled VBN O
mutation NN O
data NNS O
, , O
we PRP O
demonstrated VBD O
clustering VBG O
of IN O
WASP NNP O
mutations NNS O
within IN O
the DT O
four CD O
most JJS O
N NNP O
- : O
terminal JJ O
exons NNS O
of IN O
the DT O
gene NN O
and CC O
also RB O
identified VBD O
several JJ O
sites NNS O
within IN O
this DT O
region NN O
as IN O
hotspots NNS O
for IN O
WASP NNP O
mutation NN O
. . O

One CD O
possibility NN O
might MD O
be VB O
that IN O
individuals NNS O
who WP O
are VBP O
compound VBN O
heterozygotes NNS O
for IN O
ATM NNP O
mutations NNS O
are VBP O
more RBR O
common JJ O
than IN O
we PRP O
realize VBP O
. . O
. . O

This DT O
difference NN O
in IN O
mutation NN O
sites NNS O
may MD O
affect VB O
the DT O
clinical JJ O
features NNS O
of IN O
GLD NNP B-Disease
. . O

The DT O
Type NNP O
II NNP O
C2 NNP O
null JJ O
allele NN O
( ( O
C2Q0 NNP O
) ) O
is VBZ O
linked VBN O
to TO O
two CD O
major JJ O
histocompatibility NN O
haplotypes NNS O
( ( O
MHC NNP O
) ) O
that WDT O
differ VBP O
from IN O
the DT O
MHC NNP O
of IN O
the DT O
more RBR O
common JJ O
Type NNP B-Disease
I PRP I-Disease
C2 NNP I-Disease
deficiency NN I-Disease
. . O

The DT O
ATM NNP O
protein NN O
is VBZ O
a DT O
single JJ O
, , O
high JJ O
- : O
molecular JJ O
weight NN O
protein NN O
predominantly RB O
confined VBN O
to TO O
the DT O
nucleus NN O
of IN O
human JJ O
fibroblasts NNS O
, , O
but CC O
is VBZ O
present JJ O
in IN O
both DT O
nuclear JJ O
and CC O
microsomal JJ O
fractions NNS O
from IN O
human JJ O
lymphoblast NN O
cells NNS O
and CC O
peripheral JJ O
blood NN O
lymphocytes NNS O
. . O

R841W NN O
is VBZ O
likely JJ O
to TO O
be VB O
an DT O
etiologically RB O
significant JJ O
lesion NN O
with IN O
involvement NN O
in IN O
close JJ O
to TO O
1 CD O
% NN O
( ( O
95 CD O
% NN O
confidence NN O
interval NN O
of IN O
0 CD O
- : O
1 CD O
. . O
7 CD O
% NN O
) ) O
of IN O
all DT O
breast NN B-Disease
and CC I-Disease
ovarian JJ I-Disease
cancers NNS I-Disease
in IN O
this DT O
population NN O
. . O

OBJECTIVE NNP O
. . O

13105 CD O
. . O

The DT O
G230E NNP O
mutation NN O
causes VBZ O
substantial JJ O
changes NNS O
in IN O
anion NN O
and CC O
cation NN O
selectivity NN O
as RB O
well RB O
as IN O
a DT O
fundamental JJ O
change NN O
in IN O
rectification NN O
of IN O
the DT O
current JJ O
- : O
voltage NN O
relationship NN O
. . O

Tumor NNP B-Disease
suppression NN O
and CC O
apoptosis NN O
of IN O
human JJ O
prostate NN B-Disease
carcinoma NN I-Disease
mediated VBN O
by IN O
a DT O
genetic JJ O
locus NN O
within IN O
human JJ O
chromosome NN O
10pter CD O
- : O
q11 NN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
have VBP O
observed VBN O
mutations NNS O
involving VBG O
codon NN O
50 CD O
in IN O
11 CD O
of IN O
37 CD O
pancreatic JJ B-Disease
tumors NNS I-Disease
. . O

Three CD O
sisters NNS O
were VBD O
shown VBN O
to TO O
suffer VB O
from IN O
fish JJ B-Disease
- : I-Disease
eye NN I-Disease
disease NN I-Disease
( ( O
FED NNP B-Disease
) ) O
, , O
a DT O
disorder NN O
which WDT O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
gene NN O
coding VBG O
for IN O
lecithin JJ O
cholesterol NN O
acyltransferase NN O
( ( O
LCAT NNP O
) ) O
. . O

A DT O
wide JJ O
spectrum NN O
of IN O
mutations NNS O
, , O
ranging VBG O
from IN O
point NN O
mutations NNS O
to TO O
large JJ O
deletions NNS O
, , O
have VBP O
been VBN O
described VBN O
in IN O
the DT O
retinoblastoma NN B-Disease
gene NN O
( ( O
RB1 NNP O
) ) O
. . O

Surprisingly RB O
, , O
investigation NN O
revealed VBD O
that IN O
the DT O
patients NNS O
complement NN O
was VBD O
normal JJ O
for IN O
all DT O
components NNS O
except IN O
C9 NNP O
, , O
which WDT O
was VBD O
functionally RB O
absent JJ O
. . O

The DT O
mutations NNS O
were VBD O
small JJ O
insertions NNS O
and CC O
deletions NNS O
and CC O
point NN O
mutations NNS O
in IN O
roughly RB O
equal JJ O
proportions NNS O
. . O
. . O

Recent JJ O
studies NNS O
suggest VBP O
that IN O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( ( O
VEGF NNP O
) ) O
mRNA NN O
is VBZ O
upregulated VBN O
in IN O
RCC NNP B-Disease
- : I-Disease
and CC I-Disease
von VB I-Disease
Hippel NNP I-Disease
- : I-Disease
Lindau NNP I-Disease
disease NN I-Disease
- : I-Disease
associated VBN I-Disease
tumors NNS I-Disease
. . O

The DT O
two CD O
genes NNS O
are VBP O
believed VBN O
to TO O
interact VB O
in IN O
a DT O
number NN O
of IN O
pathways NNS O
, , O
including VBG O
regulation NN O
of IN O
DNA NNP O
damage NN O
- : O
induced VBN O
cell NN O
- : O
cycle NN O
checkpoints NNS O
, , O
apoptosis NN O
and CC O
radiation NN O
sensitivity NN O
, , O
and CC O
cellular JJ O
proliferation NN O
. . O

We PRP O
studied VBD O
the DT O
clinical JJ O
and CC O
radiological JJ O
features NNS O
in IN O
81 CD O
patients NNS O
from IN O
the DT O
literature NN O
and CC O
5 CD O
own JJ O
patients NNS O
trying VBG O
to TO O
identify VB O
distinct JJ O
subgroups NNS O
. . O

55 CD O
( ( O
P NNP O
= NNP O
. . O
2 CD O
) ) O
; : O
after IN O
additional JJ O
adjustment NN O
for IN O
HDL NNP O
levels NNS O
, , O
the DT O
RR NNP O
was VBD O
1 CD O
. . O

Pleiotropic NNP O
defects NNS O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
protein SYM O
- : O
deficient NN O
mice NN O
. . O

RT NNP O
- : O
PCR NN O
analysis NN O
shows VBZ O
that IN O
this DT O
gene NN O
, , O
which WDT O
we PRP O
have VBP O
called VBN O
DM NNP B-Disease
locus SYM O
- : O
associated VBN O
homeodomain NN O
protein NN O
( ( O
DMAHP NNP O
) ) O
, , O
is VBZ O
expressed VBN O
in IN O
a DT O
number NN O
of IN O
human JJ O
tissues NNS O
, , O
including VBG O
skeletal JJ O
muscle NN O
, , O
heart NN O
and CC O
brain NN O
. . O

After IN O
digestion NN O
with IN O
trypsin NN O
, , O
peptides NNS O
were VBD O
separated VBN O
by IN O
reversed JJ O
phase NN O
chromatography NN O
and CC O
amino NN O
acid NN O
sequenced VBD O
. . O

3 CD O
percent NN O
, , O
whereas NNS O
in IN O
patients NNS O
with IN O
DCC NNP B-Disease
- : I-Disease
negative JJ I-Disease
tumors NNS I-Disease
, , O
the DT O
survival NN O
rate NN O
was VBD O
61 CD O
. . O

Upon IN O
partial JJ O
cDNA NN O
cloning NN O
, , O
features NNS O
of IN O
the DT O
genetic JJ O
organization NN O
of IN O
LPP NNP O
were VBD O
established VBN O
. . O

Atm NNP O
- : O
deficient NN O
mice NN O
then RB O
exhibit VBD O
many JJ O
of IN O
the DT O
same JJ O
symptoms NNS O
found VBN O
in IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
patients NNS O
and CC O
in IN O
cells NNS O
derived VBN O
from IN O
them PRP O
. . O

The DT O
5 CD O
' POS O
end NN O
of IN O
the DT O
BRCA1 NNP O
gene NN O
lies VBZ O
within IN O
a DT O
duplicated JJ O
region NN O
of IN O
human JJ O
chromosome NN O
17q21 CD O
. . O

The DT O
regions NNS O
in IN O
the DT O
mouse NN O
and CC O
rat NN O
were VBD O
homologous JJ O
to TO O
human JJ O
chromosome NN O
11q CD O
. . O

In IN O
the DT O
first JJ O
family NN O
, , O
renal JJ B-Disease
lesions NNS I-Disease
were VBD O
present JJ O
in IN O
five CD O
out IN O
of IN O
six CD O
affected JJ O
individuals NNS O
, , O
whereas NNS O
HPT NNP B-Disease
and CC O
JT NNP B-Disease
were VBD O
seen VBN O
in IN O
four CD O
and CC O
two CD O
cases NNS O
, , O
respectively RB O
. . O

Exon NNP O
- : O
intron NN O
structure NN O
of IN O
the DT O
human JJ O
neuronal JJ O
nicotinic JJ O
acetylcholine NN O
receptor NN O
alpha VBD O
4 CD O
subunit NN O
( ( O
CHRNA4 NNP O
) ) O
. . O

All DT O
but CC O
one CD O
of IN O
the DT O
mutations NNS O
are VBP O
predicted VBN O
to TO O
give VB O
rise NN O
to TO O
premature VB O
translation NN O
termination NN O
and CC O
include VBP O
seven CD O
frameshift JJ O
insertions NNS O
or CC O
deletions NNS O
, , O
a DT O
nonsense JJ O
mutation NN O
, , O
and CC O
a DT O
splice NN O
acceptor NN O
site NN O
mutation NN O
. . O

Very RB O
- : O
long JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
( ( O
VLCAD NNP O
) ) O
is VBZ O
one CD O
of IN O
four CD O
straight JJ O
- : O
chain NN O
acyl IN O
- : O
CoA NNP O
dehydrogenase NN O
( ( O
ACD NNP O
) ) O
enzymes NNS O
, , O
which WDT O
are VBP O
all DT O
nuclear JJ O
encoded VBN O
mitochondrial JJ O
flavoproteins NNS O
catalyzing VBG O
the DT O
initial JJ O
step NN O
in IN O
fatty JJ O
acid NN O
beta SYM O
- : O
oxidation NN O
. . O

The DT O
protein NN O
truncation NN O
test NN O
( ( O
PTT NNP O
) ) O
was VBD O
used VBN O
on IN O
RT NNP O
- : O
PCR NN O
products NNS O
, , O
SSCP NNP O
on IN O
genomic JJ O
PCR NNP O
amplifications NNS O
, , O
and CC O
chemical JJ O
cleavage NN O
of IN O
mismatch NN O
on IN O
both DT O
RT NNP O
- : O
PCR NN O
and CC O
genomic JJ O
amplifications NNS O
. . O

The DT O
patient NN O
was VBD O
shown VBN O
to TO O
be VB O
heterozygous JJ O
for IN O
DNA NN O
markers NNS O
in IN O
the DT O
C6 NNP O
, , O
C7 NNP O
and CC O
C9 NNP O
region NN O
of IN O
chromosome NN O
5 CD O
and CC O
therefore RB O
appears VBZ O
to TO O
be VB O
a DT O
compound NN O
heterozygote NN O
for IN O
two CD O
uncharacterized JJ O
C9 NNP B-Disease
deficiency NN I-Disease
genes NNS O
. . O

atm NN O
and CC O
p53 NN O
cooperate NN O
in IN O
apoptosis NN O
and CC O
suppression NN O
of IN O
tumorigenesis NN O
, , O
but CC O
not RB O
in IN O
resistance NN O
to TO O
acute VB B-Disease
radiation NN I-Disease
toxicity NN I-Disease
. . O

In IN O
vitro JJ O
transfection NN O
studies NNS O
indicated VBD O
that IN O
the DT O
inclusion NN O
of IN O
120 CD O
bp NN O
of IN O
the DT O
5 CD O
UTR NNP O
in IN O
the DT O
cDNA NN O
construct NN O
and CC O
the DT O
presence NN O
of IN O
a DT O
frameshift JJ O
mutation NN O
at IN O
nucleotide JJ O
2349 CD O
prevented JJ O
expression NN O
of IN O
the DT O
HD NNP B-Disease
cDNA NN O
. . O

We PRP O
here RB O
describe VBZ O
a DT O
point NN O
mutation NN O
in IN O
such JJ O
a DT O
sequence NN O
. . O

ATM NNP O
protein NN O
levels NNS O
and CC O
localization NN O
remain VBP O
constant JJ O
throughout IN O
all DT O
stages NNS O
of IN O
the DT O
cell NN O
cycle NN O
. . O

Using VBG O
reverse JJ O
transcriptase NN O
combined VBN O
with IN O
polymerase NN O
chain NN O
reactions NNS O
in IN O
the DT O
analysis NN O
of IN O
a DT O
number NN O
of IN O
lipoma NN B-Disease
cell NN O
lines NNS O
and CC O
primary JJ B-Disease
lipomas NN I-Disease
, , O
it PRP O
appeared VBD O
that IN O
LPP NNP O
is VBZ O
frequently RB O
rearranged VBN O
also RB O
in IN O
cases NNS O
without IN O
a DT O
cytogenetically RB O
detectable JJ O
involvement NN O
of IN O
3q27 CD O
- : O
q28 NN O
. . O

The DT O
current JJ O
study NN O
was VBD O
aimed VBN O
at IN O
finding VBG O
the DT O
molecular JJ O
basis NN O
of IN O
Canavan NNP B-Disease
disease NN I-Disease
in IN O
25 CD O
independent JJ O
patients NNS O
of IN O
non JJ O
- : O
Jewish JJ O
background NN O
. . O

Biochemical JJ O
fractionation NN O
of IN O
brain NN O
and CC O
liver NN O
tissues NNS O
showed VBD O
that IN O
emerin NN O
was VBD O
present JJ O
in IN O
nuclei JJ O
purified VBN O
by IN O
centrifugation NN O
through IN O
65 CD O
% NN O
sucrose NN O
and CC O
was VBD O
absent NN O
from IN O
soluble JJ O
fractions NNS O
( ( O
post NN O
- : O
100 CD O
, , O
0 CD O
g NN O
) ) O
. . O

Meiotic JJ O
drive NN O
at IN O
the DT O
myotonic JJ B-Disease
dystrophy NN I-Disease
( ( O
DM NNP B-Disease
) ) O
locus NN O
has VBZ O
recently RB O
been VBN O
suggested VBN O
as IN O
being VBG O
responsible JJ O
for IN O
maintaining VBG O
the DT O
frequency NN O
, , O
in IN O
the DT O
human JJ O
population NN O
, , O
of IN O
DM NNP B-Disease
chromosomes NNS O
capable JJ O
of IN O
expansion NN O
to TO O
the DT O
disease NN O
state NN O
. . O

Abnormal NNP O
myotonic JJ B-Disease
dystrophy NN I-Disease
protein NN O
kinase NN O
levels NNS O
produce VBP O
only RB O
mild JJ O
myopathy NNS B-Disease
in IN O
mice NN O
. . O

Muscles NNS O
from IN O
mature NN O
mice NN O
show NN O
variation NN O
in IN O
fibre JJ O
size NN O
, , O
increased VBD O
fibre JJ B-Disease
degeneration NN I-Disease
and CC O
fibrosis NN B-Disease
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
the DT O
pathogenesis NN O
of IN O
HD NNP B-Disease
is VBZ O
not RB O
mediated VBN O
through IN O
DNA NNP O
- : O
protein NN O
interaction NN O
and CC O
that DT O
presence NN O
of IN O
the DT O
RNA NNP O
transcript NN O
with IN O
an DT O
expanded VBN O
CAG NNP O
repeat NN O
is VBZ O
insufficient JJ O
to TO O
cause VB O
the DT O
disease NN O
. . O

In IN O
case NN O
2 CD O
, , O
a DT O
homozygous JJ O
2 CD O
- : O
bp NN O
deletion NN O
( ( O
2137delTG CD O
/ RB O
2138delGT CD O
/ JJ O
2139delTG CD O
) ) O
caused VBD O
a DT O
frameshift NN O
, , O
generating VBG O
a DT O
premature NN O
termination NN O
codon VBZ O
4 CD O
to TO O
6 CD O
nucleotides NNS O
downstream NN O
. . O

We PRP O
therefore RB O
investigated VBD O
the DT O
expression NN O
of IN O
VHL NNP B-Disease
mRNA NN O
during IN O
human JJ O
embryogenesis NN O
by IN O
in IN O
situ JJ O
hybridization NN O
studies NNS O
at IN O
4 CD O
, , O
6 CD O
and CC O
10 CD O
weeks NNS O
post NN O
conception NN O
. . O

Adrenal JJ B-Disease
insufficiency NN I-Disease
( ( O
Addisons NNP B-Disease
disease NN I-Disease
) ) O
is VBZ O
frequently RB O
associated VBN O
with IN O
AMN NNP B-Disease
or CC O
cerebral JJ B-Disease
ALD NNP I-Disease
and CC O
may MD O
remain VB O
the DT O
only JJ O
clinical JJ O
expression NN O
of IN O
ALD NNP B-Disease
( ( O
8 CD O
% NN O
of IN O
cases NNS O
) ) O
. . O

We PRP O
have VBP O
identified VBN O
14 CD O
families NNS O
with IN O
ataxia JJ B-Disease
- : I-Disease
telangiectasia NN I-Disease
( ( O
A DT B-Disease
- : I-Disease
T NN I-Disease
) ) O
in IN O
which WDT O
mutation NN O
of IN O
the DT O
ATM NNP O
gene NN O
is VBZ O
associated VBN O
with IN O
a DT O
less RBR O
severe JJ O
clinical JJ O
and CC O
cellular JJ O
phenotype NN O
( ( O
approximately RB O
10 CD O
% NN O
- : O
15 CD O
% NN O
of IN O
A NNP B-Disease
- : I-Disease
T NN I-Disease
families NNS O
identified VBN O
in IN O
the DT O
United NNP O
Kingdom NNP O
) ) O
. . O

Homozygous JJ O
Brca1 NNP O
( ( O
5 CD O
- : O
6 CD O
) ) O
mutant NN O
mice NN O
die NN O
before IN O
day NN O
7 CD O
. . O

All PDT O
the DT O
mAbs NN O
recognised VBD O
a DT O
34 CD O
kDa NN O
protein NN O
in IN O
all DT O
tissues NNS O
tested VBN O
, , O
though IN O
minor JJ O
emerin SYM O
- : O
related JJ O
bands NNS O
were VBD O
also RB O
detected VBN O
in IN O
some DT O
tissues NNS O
. . O

Here RB O
we PRP O
investigate VBP O
the DT O
rate NN O
of IN O
BRCA2 NNP O
mutation NN O
in IN O
sporadic JJ B-Disease
breast NN I-Disease
cancers NNS I-Disease
and CC O
in IN O
a DT O
set NN O
of IN O
cell NN O
lines NNS O
that WDT O
represent VBP O
twelve VB O
other JJ O
tumour JJ B-Disease
types NNS O
. . O

In IN O
yeast NN O
, , O
mutations NNS O
in IN O
several JJ O
genes NNS O
, , O
including VBG O
RTH NNP O
and CC O
MSH3 NNP O
, , O
cause NN O
microsatellite JJ O
instability NN O
. . O

Immunofluorescence NN O
microscopy NN O
showed VBD O
that IN O
emerin NN O
is VBZ O
located VBN O
at IN O
the DT O
nuclear JJ O
rim NN O
in IN O
all DT O
tissues NNS O
examined VBN O
. . O

Targeted VBN O
disruption NN O
of IN O
ATM NNP O
leads VBZ O
to TO O
growth NN B-Disease
retardation NN I-Disease
, , O
chromosomal JJ B-Disease
fragmentation NN I-Disease
during IN I-Disease
meiosis NN I-Disease
, , O
immune JJ B-Disease
defects NNS I-Disease
, , O
and CC O
thymic JJ B-Disease
lymphoma NN I-Disease
. . O

G6PD NNP O
Santamaria NNP O
might MD O
have VB O
been VBN O
produced VBN O
by IN O
recombination NN O
between IN O
G6PD NNP O
A NNP O
and CC O
G6PD NNP O
Malaga NNP O
; : O
however RB O
haplotype NN O
analysis NN O
, , O
including VBG O
the DT O
use NN O
of IN O
a DT O
new JJ O
silent JJ O
polymorphism NN O
, , O
suggests VBZ O
that IN O
the DT O
same JJ O
542 CD O
A NNP O
- : O
- : O
> NN O
T NNP O
mutation NN O
has VBZ O
taken VBN O
place NN O
independently RB O
in IN O
a DT O
G6PD NNP O
B NNP O
gene NN O
to TO O
give VB O
G6PD NNP O
Malaga NNP O
and CC O
in IN O
a DT O
G6PD NNP O
A NNP O
gene NN O
to TO O
give VB O
G6PD NNP O
Santamaria NNP O
. . O

By IN O
electrophysiological JJ O
tests NNS O
and CC O
magnetic JJ O
resonance NN O
imaging VBG O
it PRP O
was VBD O
determined VBN O
that IN O
two CD O
patients NNS O
had VBD O
cerebral JJ B-Disease
ALD NNP I-Disease
, , O
one CD O
had VBD O
adrenomyeloneuropathy VBN B-Disease
with IN O
cerebral JJ O
involvement NN O
, , O
and CC O
two CD O
had VBD O
preclinical JJ O
AMN NNP B-Disease
. . O

Furthermore RB O
, , O
the DT O
complemented JJ O
hybrids NNS O
undergo NN O
programmed VBD O
cell NN O
death NN O
in IN O
vitro NN O
via IN O
a DT O
mechanism NN O
that WDT O
does VBZ O
not RB O
require VB O
nuclear JJ O
localization NN O
of IN O
p53 NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
IDDM2 NNP O
is VBZ O
involved VBN O
in IN O
the DT O
genetic JJ O
susceptibility NN O
to TO O
IDDM NNP B-Disease
in IN O
Japanese NNP O
. . O

The DT O
haplotype NN O
has VBZ O
been VBN O
found VBN O
in IN O
combination NN O
with IN O
a DT O
number NN O
of IN O
other JJ O
haplotypes NNS O
containing VBG O
defective JJ O
genes NNS O
that WDT O
lead VBP O
either DT O
to TO O
C6 NNP B-Disease
or CC I-Disease
C7 NNP I-Disease
deficiency NN I-Disease
, , O
but CC O
with IN O
different JJ O
consequences NNS O
. . O

Five CD O
families NNS O
( ( O
22 CD O
% NN O
) ) O
provided VBD O
evidence NN O
against IN O
linkage NN O
to TO O
both DT O
BRCA1 NNP O
and CC O
BRCA2 NNP O
. . O

This DT O
type NN O
of IN O
inversion NN O
appeared VBD O
to TO O
be VB O
conserved VBN O
in IN O
the DT O
three CD O
rodent NN O
species NNS O
, , O
mouse NN O
, , O
rat NN O
, , O
and CC O
Syrian JJ O
hamster NN O
, , O
using VBG O
additional JJ O
comparative JJ O
mapping NN O
data NNS O
with IN O
the DT O
Rck NNP O
gene NN O

Classical JJ O
phenylketonuria NN B-Disease
( ( O
PKU NNP B-Disease
) ) O
is VBZ O
an DT O
autosomal JJ B-Disease
recessive JJ I-Disease
disorder NN I-Disease
caused VBN O
by IN O
a DT O
deficiency NN B-Disease
of IN I-Disease
hepatic JJ I-Disease
phenylalanine NN I-Disease
hydroxylase NN I-Disease
( ( O
PAH NNP O
) ) O
. . O

A DT O
clinical JJ O
overview NN O
of IN O
WT1 NNP O
gene NN O
mutations NNS O
. . O

Women NNS O
who WP O
carry VBP O
a DT O
mutation NN O
in IN O
the DT O
BRCA1 NNP O
gene NN O
( ( O
on IN O
chromosome NN O
17q21 CD O
) ) O
, , O
have VBP O
an DT O
80 CD O
% NN O
risk NN O
of IN O
breast NN B-Disease
cancer NN I-Disease
and CC O
a DT O
40 CD O
% NN O
risk NN O
of IN O
ovarian JJ B-Disease
cancer NN I-Disease
by IN O
the DT O
age NN O
of IN O
70 CD O
( ( O
ref NN O
. . O
1 CD O
) ) O
. . O

Transcription NN O
of IN O
PAX3 NNP O
- : O
FKHR NNP O
is VBZ O
increased VBN O
relative JJ O
to TO O
wild VB O
- : O
type NN O
PAX3 NNP O
by IN O
a DT O
copy NN O
number NN O
- : O
independent JJ O
process NN O
. . O

Mutations NNS O
in IN O
the DT O
diastrophic JJ B-Disease
dysplasia NN I-Disease
sulfate NN O
transporter NN O
gene NN O
DTDST NNP O
have VBP O
been VBN O
associated VBN O
with IN O
a DT O
family NN O
of IN O
chondrodysplasias NN B-Disease
that WDT O
comprises VBZ O
, , O
in IN O
order NN O
of IN O
increasing VBG O
severity NN O
, , O
diastrophic JJ B-Disease
dysplasia NN I-Disease
( ( O
DTD NNP B-Disease
) ) O
, , O
atelosteogenesis NN B-Disease
type NN I-Disease
2 CD I-Disease
( ( O
AO2 NNP B-Disease
) ) O
, , O
and CC O
achondrogenesis NN B-Disease
type NN I-Disease
1B CD I-Disease
( ( O
ACG1B NNP B-Disease
) ) O
. . O

D NNP O
- : O
1 CD O
increases NNS O
, , O
whereas NNS O
D NNP O
- : O
2 CD O
decreases NNS O
GALT NNP O
activity NN O
. . O

Adult NNP B-Disease
onset MD I-Disease
globoid VB I-Disease
cell NN I-Disease
leukodystrophy NN I-Disease
( ( O
Krabbe NNP B-Disease
disease NN I-Disease
) ) O
: : O
analysis NN O
of IN O
galactosylceramidase NN O
cDNA NN O
from IN O
four CD O
Japanese JJ O
patients NNS O
. . O

The DT O
remaining VBG O
mutation NN O
is VBZ O
a DT O
missense JJ O
mutation NN O
( ( O
Cys61Gly NNP O
) ) O
in IN O
the DT O
zinc NN O
- : O
binding NN O
motif NN O
. . O

Within IN O
the DT O
kidney NN O
, , O
VHL NNP B-Disease
mRNA NN O
was VBD O
differentially RB O
expressed VBN O
within IN O
renal JJ O
tubules NNS O
suggesting VBG O
that IN O
the DT O
VHL NNP B-Disease
gene NN O
product NN O
may MD O
have VB O
a DT O
specific JJ O
role NN O
in IN O
kidney NN O
development NN O
. . O

However RB O
, , O
in IN O
the DT O
229 CD O
female NN O
controls NNS O
in IN O
whom WP O
family NN O
history NN O
of IN O
cancer NN B-Disease
was VBD O
known VBN O
, , O
one CD O
of IN O
two CD O
who WP O
had VBD O
a DT O
sister NN O
with IN O
breast NN B-Disease
cancer NN I-Disease
was VBD O
carrying VBG O
the DT O
variant JJ O
allele NN O
. . O

3 CD O
percent NN O
and CC O
33 CD O
. . O

However RB O
, , O
one CD O
or CC O
more JJR O
additional JJ O
genes NNS O
may MD O
yet RB O
be VB O
found VBN O
that IN O
explain VBP O
some DT O
proportion NN O
of IN O
hereditary JJ B-Disease
breast NN I-Disease
cancer NN I-Disease
. . O
. . O

390X CD O
+ JJ O
0 CD O
. . O

Insulin NN O
treatment NN O
also RB O
prevented VBD O
the DT O
increases NNS O
in IN O
contractile JJ O
responses NNS O
of IN O
bladder NN O
body NN O
strips NNS O
from IN O
diabetic JJ O
rats NNS O
to IN O
nerve NN O
stimulation NN O
, , O
ATP NNP B-Chemical
, , O
and CC O
bethanechol NN B-Chemical
. . O

The DT O
most RBS O
common JJ O
symptomatic JJ O
adverse JJ O
reactions NNS O
were VBD O
tremor NN O
or CC O
ataxia NN O
( , O
35 CD O
% NN O
) -RRB- O
, , O
nausea NN O
and CC O
anorexia NN O
( : O
8 CD O
% NN O
) -RRB- O
, , O
visual JJ O
halos NNS O
or CC O
blurring NN O
( , O
6 CD O
% NN O
) -RRB- O
, , O
thyroid NN O
function NN O
abnormalities NNS O
( : O
6 CD O
% NN O
) -RRB- O
and CC O
pulmonary JJ O
interstitial JJ O
infiltrates NNS O
( : O
5 CD O
% NN O
) -RRB- O
. . O

The DT O
heparin NN B-Chemical
- HYPH O
induced VBN O
platelet NN O
aggregation NN O
test NN O
was VBD O
negative JJ O
in IN O
these DT O
patients NNS O
. . O

Open JJ O
- HYPH O
label NN O
assessment NN O
of IN O
levofloxacin NN B-Chemical
for IN O
the DT O
treatment NN O
of IN O
acute JJ O
bacterial JJ O
sinusitis NN O
in IN O
adults NNS O
. . O

BACKGROUND NN O
: : O
Calcitriol NNP B-Chemical
therapy NN O
suppresses VBZ O
serum JJ O
levels NNS O
of IN O
parathyroid NN O
hormone NN O
( -LRB- O
PTH NN O
) -RRB- O
in IN O
patients NNS O
with IN O
renal JJ O
failure NN O
but CC O
has VBZ O
several JJ O
drawbacks NNS O
, , O
including VBG O
hypercalcemia NN O
and CC O
/ SYM O
or CC O
marked VBN O
suppression NN O
of IN O
bone NN O
turnover NN O
, , O
which WDT O
may MD O
lead VB O
to IN O
adynamic JJ O
bone NN O
disease NN O
. . O

BACKGROUND NN O
: : O
In IN O
recent JJ O
studies NNS O
increased VBN O
amounts NNS O
of IN O
nitric JJ B-Chemical
oxide NN I-Chemical
( -LRB- O
NO NN B-Chemical
) -RRB- O
and CC O
apoptosis NN O
have VBP O
been VBN O
implicated VBN O
in IN O
various JJ O
pathological JJ O
conditions NNS O
in IN O
the DT O
kidney NN O
. . O

We PRP O
report VBP O
the DT O
occurrence NN O
of IN O
a DT O
generalized JJ O
tonic NN O
- HYPH O
clonic JJ O
seizure NN O
in IN O
a DT O
pediatric JJ O
patient NN O
following VBG O
the DT O
administration NN O
of IN O
flumazenil NN B-Chemical
. . O

One CD O
of IN O
these DT O
patients NNS O
developed VBD O
a DT O
myocardial JJ O
infarction NN O
before IN O
receiving VBG O
any DT O
medication NN O
, , O
shortly RB O
after IN O
the DT O
base NN O
- HYPH O
line NN O
values NNS O
were VBD O
obtained VBN O
. . O

Reduced VBN O
sodium NN B-Chemical
channel NN O
density NN O
, , O
altered VBN O
voltage NN O
dependence NN O
of IN O
inactivation NN O
, , O
and CC O
increased VBN O
susceptibility NN O
to IN O
seizures NNS O
in IN O
mice NNS O
lacking VBG O
sodium NN B-Chemical
channel NN O
beta NN O
2 CD O
- HYPH O
subunits NNS O
. . O

In IN O
a DT O
second JJ O
experiment NN O
, , O
rats NNS O
received VBD O
tricyclic JJ O
antidepressant JJ O
desipramine NN B-Chemical
IP NN O
followed VBN O
in IN O
15 CD O
min NN O
by IN O
4 CD B-Chemical
- HYPH I-Chemical
aminopyridine NN I-Chemical
or CC O
saline NN O
. . O

The DT O
estimated VBN O
attributable JJ O
risk NN O
of IN O
ototoxicity NN O
from IN O
exposure NN O
to IN O
the DT O
drug NN O
is VBZ O
8 CD O
. . O
4 CD O
% NN O
( : O
95 CD O
% NN O
confidence NN O
interval NN O
, , O
- : O
2 CD O
. . O
0 CD O
% NN O
to TO O
18 CD O
. . O
8 CD O
% NN O
; : O
P NN O
= SYM O
0 CD O
. . O
12 CD O
) -RRB- O
. . O

The DT O
purpose NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
changes NNS O
in IN O
plasma NN O
and CC O
urinary JJ O
lipoproteins NNS O
during IN O
the DT O
administration NN O
of IN O
puromycin NN B-Chemical
aminonucleoside NN I-Chemical
( SYM O
20 CD O
mg NN O
/ SYM O
kg NN O
for IN O
7 CD O
days NNS O
) -RRB- O
and CC O
the DT O
subsequent JJ O
development NN O
of IN O
nephrotic JJ O
syndrome NN O
. . O

Pulse NN O
power NN O
analysis NN O
may MD O
be VB O
helpful JJ O
in IN O
determining VBG O
the DT O
etiology NN O
of IN O
and CC O
treating VBG O
hypotension NN O
during IN O
cesarean JJ O
delivery NN O
under IN O
neuraxial JJ O
anesthesia NN O
. . O

It PRP O
appears VBZ O
that IN O
methylphenidate NN B-Chemical
precipitated VBD O
the DT O
patient NN O
' POS O
s POS O
pathological JJ O
behavior NN O
. . O

The DT O
findings NNS O
of IN O
this DT O
study NN O
suggest VBP O
that IN O
lesions NNS O
of IN O
the DT O
unilateral JJ O
STN NNP O
and CC O
GPi NNP O
are VBP O
equally RB O
effective JJ O
treatment NN O
for IN O
patients NNS O
with IN O
advanced JJ O
PD NN O
refractory NN O
to IN O
medical JJ O
treatment NN O
. . O

Of IN O
388 CD O
liver NN O
recipients NNS O
who WP O
received VBD O
tacrolimus NN B-Chemical
as IN O
primary JJ O
immunosuppression NN O
, , O
70 CD O
required VBD O
conversion NN O
to IN O
CyA NNP O
. . O

Attenuated JJ O
disruption NN O
of IN O
prepulse JJ O
inhibition NN O
by IN O
dopaminergic JJ O
stimulation NN O
after IN O
maternal JJ O
deprivation NN O
and CC O
adolescent JJ O
corticosterone NN B-Chemical
treatment NN O
in IN O
rats NNS O
. . O

Ketoprofen NNP B-Chemical
but CC O
not RB O
acetaminophen NN B-Chemical
impaired VBN O
platelet NN O
function NN O
in IN O
patients NNS O
with IN O
SAH NNP O
. . O

Mitomycin NNP B-Chemical
C NNP I-Chemical
associated VBN O
hemolytic JJ O
uremic JJ O
syndrome NN O
. . O

Cocaine NN B-Chemical
- HYPH O
induced VBN O
paranoia NN O
( , O
CIP NNP O
) -RRB- O
remains VBZ O
an DT O
important JJ O
drug NN O
- HYPH O
induced VBN O
model NN O
of IN O
idiopathic JJ O
paranoia NN O
for IN O
which WDT O
no DT O
psychophysiologic JJ O
marker NN O
has VBZ O
yet RB O
emerged VBN O
. . O

These DT O
improvements NNS O
or CC O
normalizations NNS O
of IN O
impaired VBN O
cognitive JJ O
functions NNS O
were VBD O
seen VBN O
at IN O
oral JJ O
aniracetam NN B-Chemical
doses NNS O
of IN O
10 CD O
- SYM O
100 CD O
mg NNS O
/ SYM O
kg NN O
. . O

A DT O
further JJ O
group NN O
of IN O
25 CD O
patients NNS O
under IN O
polychemotherapy NN O
with IN O
IF NNP B-Chemical
were VBD O
treated VBN O
by IN O
conventional JJ O
prophylactic JJ O
measures NNS O
( , O
raised VBN O
fluid NN O
intake NN O
and CC O
forced VBN O
diuresis NN O
) -RRB- O
. . O

CONCLUSIONS NNS O
: : O
Ethambutol NNP B-Chemical
usage NN O
is VBZ O
associated VBN O
with IN O
permanent JJ O
visual JJ O
loss NN O
and CC O
should MD O
be VB O
avoided VBN O
if IN O
possible JJ O
or CC O
used VBN O
with IN O
caution NN O
and CC O
proper JJ O
ophthalmological JJ O
follow NN O
- HYPH O
up NN O
. . O

Expression NN O
of IN O
p300 NN O
protects VBZ O
cardiac JJ O
myocytes NNS O
from IN O
apoptosis NN O
in IN O
vivo NN O
. . O

In IN O
the DT O
second JJ O
experiment NN O
, , O
four CD O
groups NNS O
of IN O
mice NNS O
received VBD O
similar JJ O
treatment NN O
in IN O
the DT O
first JJ O
experiment NN O
, , O
and CC O
30 CD O
min NN O
after IN O
these DT O
injections NNS O
, , O
all DT O
mice NNS O
received VBD O
a DT O
higher JJR O
dose NN O
of IN O
lidocaine NN B-Chemical
( : O
80 CD O
mg NNS O
/ SYM O
kg NNS O
) -RRB- O
. . O

Several JJ O
routine JJ O
indicators NNS O
of IN O
nephrotoxicity NN O
, , O
the DT O
enzymes NNS O
alkaline NN O
phosphatase NN O
and CC O
N NN O
- HYPH O
acetyl NN O
- HYPH O
beta NN O
- HYPH O
glucosaminidase NN O
, , O
and CC O
the DT O
molecular JJ O
weight NN O
of IN O
protein NN O
excretion NN O
were VBD O
determined VBN O
on IN O
urine NN O
samples NNS O
. . O

In IN O
the DT O
propranolol NN B-Chemical
group NN O
, , O
serum NN O
potassium NN B-Chemical
and CC O
uric NN B-Chemical
acid NN I-Chemical
levels NNS O
rose VBD O
in IN O
both DT O
sexes NNS O
, , O
but CC O
the DT O
urea NN B-Chemical
level NN O
rose VBD O
significantly RB O
in IN O
women NNS O
only RB O
. . O

The DT O
memory NN O
- HYPH O
enhancing VBG O
effects NNS O
of IN O
PREGS NNS B-Chemical
and CC O
its PRP$ O
analogs NNS O
were VBD O
tested VBN O
in IN O
the DT O
passive JJ O
avoidance NN O
task NN O
using VBG O
the DT O
model NN O
of IN O
scopolamine NN B-Chemical
- HYPH O
induced VBN O
amnesia NN O
. . O

Oral JJ O
administration NN O
of IN O
captopril NN B-Chemical
at IN O
100 CD O
mg NNS O
/ SYM O
kg NN O
for IN O
14 CD O
days NNS O
failed VBD O
to TO O
aggravate VB O
proteinuria NN O
pre NN O
- HYPH O
existing VBG O
in IN O
SHR NNP O
. . O

OBJECTIVE NN O
: : O
The DT O
objective NN O
was VBD O
to TO O
examine VB O
the DT O
relation NN O
between IN O
vitamin NN B-Chemical
C NN I-Chemical
intake NN O
and CC O
mortality NN O
from IN O
cardiovascular JJ O
disease NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
randomized JJ O
, , O
double JJ O
- HYPH O
blind JJ O
, , O
prospective JJ O
study NN O
was VBD O
to TO O
investigate VB O
whether IN O
intravenous JJ O
( : O
i LS O
. . O
v NN O
. . O
) -RRB- O
administration NN O
of IN O
methylprednisolone NN B-Chemical
( -LRB- O
MP NN B-Chemical
) -RRB- O
prevents VBZ O
this DT O
complication NN O
. . O

Renal JJ O
lesions NNS O
are VBP O
similar JJ O
to IN O
those DT O
seen VBN O
in IN O
idiopathic JJ O
HUS NNP O
and CC O
include VBP O
arteriolar JJ O
fibrin NN O
thrombi NN O
, , O
expanded VBN O
subendothelial JJ O
zones NNS O
in IN O
glomerular JJ O
capillary NN O
walls NNS O
, , O
ischemic JJ O
wrinkling NN O
of IN O
glomerular JJ O
basement NN O
membranes NNS O
and CC O
mesangiolysis NN O
. . O

We PRP O
conducted VBD O
a DT O
systematic JJ O
review NN O
of IN O
the DT O
effects NNS O
of IN O
dexmedetomidine NN B-Chemical
on IN O
cardiac JJ O
outcomes NNS O
following VBG O
non JJ O
- HYPH O
cardiac JJ O
surgery NN O
. . O

Injections NNS O
of IN O
scopolamine NN B-Chemical
into IN O
mice NNS O
resulted VBD O
in IN O
impaired VBN O
performance NN O
on IN O
Y NNP O
- HYPH O
maze NN O
tests NNS O
( : O
a DT O
37 CD O
% NN O
decreases NNS O
in IN O
alternation NN O
behavior NN O
) -RRB- O
. . O

Serotonin NN B-Chemical
was VBD O
depleted VBN O
beginning VBG O
on IN O
postnatal JJ O
day NN O
26 CD O
with IN O
parachlorophenylalanine NN B-Chemical
( , O
PCPA NN B-Chemical
100 CD O
mg NN O
/ SYM O
kg NN O
, , O
every DT O
other JJ O
day NN O
) -RRB- O
; , O
controls NNS O
received VBD O
saline NN O
. . O

Local JJ O
anaesthetic JJ O
blocks NNS O
were VBD O
useful JJ O
in IN O
decreasing VBG O
the DT O
requirement NN O
for IN O
postoperative JJ O
analgesia NN O
. . O

Subsequent JJ O
treatment NN O
of IN O
persistent JJ O
hyperthyroidism NN O
with IN O
radioablation NN O
did VBD O
not RB O
result VB O
in IN O
an DT O
exacerbation NN O
of IN O
the DT O
vasculitis NN O
, , O
a DT O
complication NN O
described VBN O
in IN O
prior JJ O
case NN O
reports NNS O
. . O

Aspirin NN B-Chemical
or CC O
salicylate NN B-Chemical
ingestion NN O
had VBD O
occurred VBN O
in IN O
only RB O
one CD O
of IN O
the DT O
20 CD O
cases NNS O
( : O
5 CD O
% NN O
) -RRB- O
, , O
and CC O
paracetamol NN B-Chemical
( , O
acetaminophen NN B-Chemical
) -RRB- O
had VBD O
been VBN O
administered VBN O
in IN O
only RB O
six CD O
of IN O
the DT O
cases NNS O
( : O
30 CD O
% NN O
) -RRB- O
. . O

A DT O
significant JJ O
proliferative JJ O
response NN O
to IN O
serum NN O
collected VBN O
after IN O
dilevalol NN B-Chemical
intake NN O
was VBD O
observed VBN O
in IN O
the DT O
case NN O
of IN O
the DT O
patient NN O
compared VBN O
with IN O
the DT O
proliferative JJ O
response NN O
to IN O
the DT O
serum NN O
collected VBN O
before IN O
the DT O
drug NN O
intake NN O
. . O

Of IN O
the DT O
51 CD O
patients NNS O
, , O
7 CD O
patients NNS O
showed VBD O
asynergy NN O
with IN O
ST NNP O
elevation NN O
. . O

Physiological JJ O
dose NN O
( : O
< : O
1 CD O
mg NN O
) -RRB- O
of IN O
folic JJ B-Chemical
acid NN I-Chemical
both CC O
in IN O
healthy JJ O
and CC O
60 CD O
epileptic JJ O
women NNS O
, , O
all DT O
without IN O
any DT O
autoimmune JJ O
disease NN O
, , O
did VBD O
not RB O
increase VB O
the DT O
risk NN O
for IN O
epileptic JJ O
seizures NNS O
. . O

RESULTS NNS O
: : O
Seven CD O
patients NNS O
showed VBD O
marked JJ O
visual JJ O
field NN O
constriction NN O
with IN O
some DT O
sparing NN O
of IN O
the DT O
temporal JJ O
visual JJ O
field NN O
. . O

Two CD O
recently RB O
available JJ O
immunosuppressive JJ O
agents NNS O
, , O
mycophenolate NN B-Chemical
mofetil NN I-Chemical
and CC O
sirolimus NN B-Chemical
( , O
rapamycin NN B-Chemical
) -RRB- O
, , O
have VBP O
no DT O
nephrotoxicity NN O
. . O

Effects NNS O
of IN O
calcitonin NN O
on IN O
rat NN O
extrapyramidal JJ O
motor NN O
system NN O
: : O
behavioral JJ O
and CC O
biochemical JJ O
data NNS O
. . O

Myocardial JJ O
hypertrophy NN O
completely RB O
resolved VBN O
upon IN O
reducing VBG O
the DT O
target NN O
concentration NN O
of IN O
tacrolimus NN B-Chemical
and CC O
did VBD O
not RB O
recur VB O
, , O
as IN O
confirmed VBN O
at IN O
echocardiography NN O
and CC O
myocardial JJ O
biopsy NN O
. . O

A DT O
phase NN O
III NNP O
clinical JJ O
trial NN O
assessed VBD O
the DT O
recurrence NN O
of IN O
adenomatous JJ O
polyps NNS O
after IN O
treatment NN O
for IN O
36 CD O
months NNS O
with IN O
difluoromethylornithine NN B-Chemical
( , O
DFMO NNP B-Chemical
) -RRB- O
plus CC O
sulindac NN B-Chemical
or CC O
matched VBD O
placebos NNS O
. . O

Possible JJ O
azithromycin NN B-Chemical
- HYPH O
associated VBN O
hiccups NNS O
. . O

Based VBN O
on IN O
this DT O
model NN O
and CC O
on IN O
Bayes NNP O
' POS O
theorem NN O
, , O
the DT O
predictive JJ O
accuracy NN O
of IN O
identifying VBG O
"""" `` O
nephrotoxic JJ O
"""" '' O
patients NNS O
increased VBD O
from IN O
0 CD O
. . O
17 CD O
to IN O
0 CD O
. . O
39 CD O
. . O

The DT O
present JJ O
study NN O
points VBZ O
to IN O
patient JJ O
characteristics NNS O
that WDT O
may MD O
be VB O
of IN O
significance NN O
in IN O
the DT O
development NN O
of IN O
EPS NNP O
due IN O
to IN O
haloperidol NN B-Chemical
. . O

Furthermore RB O
, , O
immunohistochemical JJ O
studies NNS O
demonstrated VBD O
that IN O
VEGFR NNP O
- HYPH O
2 CD O
( HYPH O
flk NN O
- HYPH O
1 CD O
/ SYM O
KDR NN O
) -RRB- O
, , O
expression NN O
was VBD O
elevated VBN O
significantly RB O
in IN O
the DT O
endothelial JJ O
cells NNS O
of IN O
microblood NN O
vessels NNS O
after IN O
7 CD O
days NNS O
of IN O
E2 NNP B-Chemical
exposure NN O
. . O

The DT O
mechanism NN O
and CC O
clinical JJ O
significance NN O
of IN O
these DT O
ECG NNP O
changes NNS O
remain VBP O
to TO O
be VB O
determined VBN O
. . O

In IN O
the DT O
frontal JJ O
cortex NN O
, , O
there EX O
was VBD O
a DT O
statistically RB O
significant JJ O
decrease NN O
in IN O
GSK3alpha NNP O
after IN O
multiple JJ O
( , O
but CC O
not RB O
single JJ O
) -RRB- O
injections NNS O
of IN O
METH NNP B-Chemical
. . O

In IN O
contrast NN O
, , O
2R CD B-Chemical
, , I-Chemical
4R NNP I-Chemical
- HYPH I-Chemical
APDC NNP I-Chemical
injections NNS O
were VBD O
ineffective JJ O
. . O

Compared VBN O
with IN O
the DT O
score NN O
at IN O
rest NN O
( : O
1 CD O
. . O
3 CD O
+ SYM O
/ SYM O
- HYPH O
0 CD O
. . O
3 CD O
) -RRB- O
, , O
a DT O
significant JJ O
aggravation NN O
of IN O
the DT O
dyskinesia NN O
score NN O
was VBD O
observed VBN O
during IN O
speaking VBG O
aloud RB O
( , O
5 CD O
. . O
2 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
1 CD O
, , O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
, , O
movements NNS O
of IN O
right JJ O
( : O
4 CD O
. . O
5 CD O
+ CD O
/ SYM O
- HYPH O
1 CD O
. . O
0 CD O
, , O
p NN O
< CC O
0 CD O
. . O
05 CD O
) NFP O
and CC O
left RB O
( : O
3 CD O
. . O
7 CD O
+ CD O
/ SYM O
- HYPH O
0 CD O
. . O
8 CD O
, , O
p NN O
< NN O
0 CD O
. . O
05 CD O
) SYM O
fingers NNS O
, , O
movements NNS O
of IN O
the DT O
neck NN O
( , O
5 CD O
. . O
1 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
0 CD O
, , O
p NN O
< NN O
0 CD O
. . O
05 CD O
) NFP O
, , O
and CC O
mental JJ O
calculation NN O
( : O
3 CD O
. . O
1 CD O
+ SYM O
/ SYM O
- HYPH O
1 CD O
. . O
0 CD O
, , O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

Fluconazole NNP B-Chemical
- HYPH O
induced VBN O
torsade NN O
de FW O
pointes FW O
. . O

CONCLUSION NN O
: : O
HTR6 NNP O
may MD O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
pathophysiology NN O
of IN O
METH NNP B-Chemical
- HYPH O
induced VBN O
psychosis NN O
in IN O
the DT O
Japanese JJ O
population NN O
. . O

Recent JJ O
data NNS O
suggest VBP O
that IN O
tricyclic JJ O
antidepressants NNS O
inhibit VBP O
calcium NN B-Chemical
influx NN O
in IN O
some DT O
tissues NNS O
. . O

By IN O
multivariate JJ O
analysis NN O
, , O
in IN O
both CC O
the DT O
placebo NN O
and CC O
enalapril NN B-Chemical
groups NNS O
older JJR O
age NN O
, , O
diuretic JJ B-Chemical
therapy NN O
, , O
and CC O
diabetes NN O
were VBD O
associated VBN O
with IN O
decreased VBN O
renal JJ O
function NN O
, , O
whereas IN O
beta NN O
- HYPH O
blocker NN O
therapy NN O
and CC O
higher JJR O
ejection NN O
fraction NN O
were VBD O
renoprotective JJ O
. . O

Discontinuation NN O
of IN O
azithromycin NN B-Chemical
and CC O
therapy NN O
with IN O
baclofen NN B-Chemical
finally RB O
resolved VBD O
hiccups NNS O
. . O

The DT O
administration NN O
of IN O
calcium NN B-Chemical
chloride NN I-Chemical
rapidly RB O
resolved VBD O
the DT O
patient NN O
' '' O
s POS O
tetany NN O
with IN O
prompt JJ O
recovery NN O
of IN O
respiratory JJ O
function NN O
, , O
averting VBG O
the DT O
need NN O
for IN O
more RBR O
aggressive JJ O
airway NN O
management NN O
and CC O
ventilatory JJ O
support NN O
. . O

Acute JJ O
and CC O
chronic JJ O
nephrotoxicity NN O
is VBZ O
becoming VBG O
more RBR O
common JJ O
as IN O
the DT O
use NN O
of IN O
marginal JJ O
kidneys NNS O
for IN O
transplantation NN O
increases VBZ O
. . O

No DT O
significant JJ O
change NN O
in IN O
myocardial JJ O
oxygen NN B-Chemical
consumption NN O
occurred VBD O
after IN O
ouabain NN B-Chemical
administration NN O
but CC O
this DT O
may MD O
be VB O
related VBN O
to IN O
a DT O
greater JJR O
decrease NN O
in IN O
mean JJ O
arterial JJ O
pressure NN O
in IN O
the DT O
ouabain JJ B-Chemical
patients NNS O
than IN O
in IN O
the DT O
control NN O
patients NNS O
. . O

Immune JJ O
hemolytic JJ O
anemia NN O
due IN O
to IN O
a DT O
drug NN O
- HYPH O
adsorption NN O
mechanism NN O
has VBZ O
been VBN O
described VBN O
primarily RB O
in IN O
patients NNS O
receiving VBG O
penicillins NNS B-Chemical
and CC O
first JJ O
- HYPH O
generation NN O
cephalosporins NNS B-Chemical
. . O

The DT O
mean JJ O
BIS NNP O
score NN O
corresponding VBG O
to IN O
the DT O
first JJ O
word NN O
recalled VBN O
after IN O
the DT O
procedure NN O
was VBD O
completed VBN O
was VBD O
91 CD O
. . O
2 CD O
( SYM O
95 CD O
% NN O
CI NN O
= SYM O
88 CD O
. . O
1 CD O
to TO O
94 CD O
. . O
3 CD O
) -RRB- O
. . O

The DT O
control NN O
group NN O
received VBD O
fluids NNS O
( , O
mean JJ O
3 CD O
liters NNS O
) -RRB- O
. . O

A DT O
muscle NN O
biopsy NN O
in IN O
this DT O
patient NN O
showed VBD O
loss NN O
of IN O
thick JJ O
, , O
myosin NN O
filaments NNS O
. . O

Contribution NN O
of IN O
the DT O
glycine NN B-Chemical
site NN O
of IN O
NMDA NNP B-Chemical
receptors NNS O
in IN O
rostral JJ O
and CC O
intermediate JJ O
- HYPH O
caudal JJ O
parts NNS O
of IN O
the DT O
striatum NN O
to IN O
the DT O
regulation NN O
of IN O
muscle NN O
tone NN O
in IN O
rats NNS O
. . O

Mice NNS O
lacking VBG O
mPGES NNP O
- HYPH O
1 CD O
are VBP O
resistant JJ O
to IN O
lithium NN B-Chemical
- HYPH O
induced VBN O
polyuria NN O
. . O

Haloperidol NNP B-Chemical
- HYPH O
induced VBN O
catalepsy NN O
was VBD O
challenged VBN O
with IN O
prior JJ O
intracollicular JJ O
microinjections NNS O
of IN O
glutamate NN B-Chemical
NMDA NNP B-Chemical
receptor NN O
antagonists NNS O
, , O
MK NNP B-Chemical
- HYPH I-Chemical
801 CD I-Chemical
( SYM O
15 CD O
or CC O
30 CD O
mmol NN O
/ SYM O
0 CD O
. . O
5 CD O
microl NN O
) -RRB- O
and CC O
AP7 NNP B-Chemical
( SYM O
10 CD O
or CC O
20 CD O
nmol NN O
/ SYM O
0 CD O
. . O
5 CD O
microl NN O
) -RRB- O
, , O
or CC O
of IN O
the DT O
NMDA NNP B-Chemical
receptor NN O
agonist NN O
N NNP B-Chemical
- HYPH I-Chemical
methyl NN I-Chemical
- HYPH I-Chemical
d NNP I-Chemical
- HYPH I-Chemical
aspartate NN I-Chemical
( , O
NMDA NNP B-Chemical
, , O
20 CD O
or CC O
30 CD O
nmol NN O
/ SYM O
0 CD O
. . O
5 CD O
microl NN O
) -RRB- O
. . O

Spontaneous JJ O
coronary JJ O
thrombosis NN O
or CC O
thromboembolism NN O
with IN O
subsequent JJ O
clot NN O
lysis NN O
has VBZ O
been VBN O
suggested VBN O
as IN O
one CD O
of IN O
the DT O
most RBS O
common JJ O
causes NNS O
of IN O
myocardial JJ O
infarction NN O
( , O
MI NNP O
) -RRB- O
during IN O
pregnancy NN O
, , O
with IN O
a DT O
subsequently RB O
normal JJ O
coronary JJ O
angiogram NN O
. . O

We PRP O
suggest VBP O
that IN O
caution NN O
be VB O
taken VBN O
when WRB O
cisapride NN B-Chemical
is VBZ O
prescribed VBN O
with IN O
any DT O
potent JJ O
inhibitor NN O
of IN O
CYP3A4 NNP O
, , O
including VBG O
diltiazem NN B-Chemical
. . O

Epileptogenic JJ O
properties NNS O
of IN O
enflurane NN B-Chemical
and CC O
their PRP$ O
clinical JJ O
interpretation NN O
. . O

Clinical JJ O
evaluation NN O
included VBD O
the DT O
use NN O
of IN O
the DT O
Unified NNP O
Parkinson NNP O
' POS O
s NNP O
Disease NNP O
Rating NNP O
Scale NNP O
( -LRB- O
UPDRS NNP O
) -RRB- O
, , O
Hoehn NNP O
_ : O
Yahr NNP O
score NN O
and CC O
Schwab NNP O
England NNP O
activities NNS O
of IN O
daily JJ O
living NN O
( , O
ADL NNP O
) -RRB- O
score NN O
in IN O
' `` O
on IN O
' '' O
- HYPH O
and CC O
' `` O
off JJ O
' '' O
- HYPH O
drug NN O
conditions NNS O
before IN O
surgery NN O
and CC O
6 CD O
months NNS O
after IN O
surgery NN O
. . O

Addition NN O
of IN O
oral JJ O
nicorandil NN B-Chemical
reduced VBD O
his PRP$ O
symptoms NNS O
and CC O
maintained VBD O
stable JJ O
angina NN O
status NN O
. . O

A DT O
full JJ O
cardiological JJ O
assessment NN O
before IN O
and CC O
during IN O
the DT O
transplant NN O
emerged VBD O
as IN O
the DT O
major JJ O
recommendation NN O
. . O

Young JJ O
women NNS O
on IN O
replacement NN O
estrogens NNS B-Chemical
for IN O
ovarian JJ O
failure NN O
after IN O
cancer NN O
therapy NN O
may MD O
also RB O
have VB O
increased VBN O
risk NN O
of IN O
endometrial JJ O
carcinoma NN O
and CC O
should MD O
be VB O
examined VBN O
periodically RB O
. . O

In IN O
contrast NN O
, , O
maximal JJ O
platelet NN O
aggregation NN O
increased VBD O
in IN O
the DT O
acetaminophen NN B-Chemical
group NN O
on IN O
the DT O
third JJ O
postoperative JJ O
day NN O
as IN O
compared VBN O
with IN O
the DT O
pretreatment NN O
platelet NN O
aggregation NN O
results NNS O
( , O
P NN O
< NN O
. . O
05 CD O
) -RRB- O
. . O

Mean JJ O
serum NN O
potassium NN B-Chemical
level NN O
fell VBD O
, , O
and CC O
urea NN B-Chemical
and CC O
uric NN B-Chemical
acid NN I-Chemical
levels NNS O
rose VBD O
, , O
in IN O
men NNS O
and CC O
women NNS O
taking VBG O
bendrofluazide NN B-Chemical
. . O

Cefotetan NN B-Chemical
- HYPH O
dependent JJ O
antibodies NNS O
were VBD O
detected VBN O
in IN O
the DT O
patient NN O
' POS O
s NNS O
serum NN O
and CC O
in IN O
an DT O
eluate NN O
prepared VBN O
from IN O
his PRP$ O
red JJ O
blood NN O
cells NNS O
. . O

Corresponding VBG O
figures NNS O
during IN O
HCTZ NNP B-Chemical
therapy NN O
100 CD O
mg CD O
daily RB O
were VBD O
1 CD O
. . O
4 CD O
+ CD O
/ SYM O
- SYM O
0 CD O
. . O
1 CD O
, , O
3 CD O
. . O
6 CD O
+ CD O
/ SYM O
- SYM O
0 CD O
. . O
7 CD O
and CC O
5 CD O
. . O
7 CD O
4 CD O
/ SYM O
- SYM O
0 CD O
. . O
8 CD O
, , O
respectively RB O
. . O

Like IN O
other JJ O
maturation NN O
processes NNS O
, , O
RNA NNP O
editing NN O
is VBZ O
an DT O
essential JJ O
post NN O
- HYPH O
transcriptional JJ O
event NN O
in IN O
plant NN O
mitochondrial JJ O
gene NN O
expression NN O
( , O
9 CD O
- HYPH O
11 CD O
) -RRB- O
required VBN O
for IN O
the DT O
synthesis NN O
of IN O
functional JJ O
proteins NNS O
( , O
12 CD O
, , O
13 CD O
) -RRB- O
. . O

Nucleic NNP O
Acids NNP O
Research NNP O

As IN O
mentioned VBN O
, , O
both CC O
MDA NNP O
- HYPH O
MB NNP O
- HYPH O
468 CD O
and CC O
BT NNP O
- HYPH O
20 CD O
display VBP O
increased VBN O
pAKT NNP O
after IN O
MUC1 NNP O
siRNA NNP O
, , O
but CC O
the DT O
ratio NN O
of IN O
active JJ O
to IN O
total JJ O
AKT NNP O
is VBZ O
considerably RB O
higher JJR O
in IN O
the DT O
BT NNP O
- HYPH O
20 CD O
line NN O
, , O
which WDT O
may MD O
help VB O
these DT O
cells NNS O
resist VB O
the DT O
increased JJ O
apoptosis NN O
expected VBN O
with IN O
loss NN O
of IN O
MUC1 NNP O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
utilize VB O
our PRP$ O
developed JJ O
apparatus NN O
and CC O
protocols NNS O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
lower JJR O
median JJ O
nerve NN O
lesion NN O
on IN O
thumb NN O
motor NN O
function NN O
. . O

In IN O
light NN O
of IN O
this DT O
, , O
our PRP$ O
results NNS O
are VBP O
in IN O
agreement NN O
with IN O
the DT O
notion NN O
that IN O
transcriptional JJ O
regulators NNS O
can MD O
also RB O
participate VB O
in IN O
defining VBG O
the DT O
boundaries NNS O
of IN O
functional JJ O
chromosomal JJ O
domains NNS O
. . O

However RB O
, , O
on IN O
day NN O
4 CD O
, , O
the DT O
patient NN B-Species
started VBD O
to TO O
complain VB O
of IN O
upper JJ O
abdominal JJ O
pain NN O
and CC O
developed VBD O
a DT O
high JJ O
grade NN O
fever NN O
( : O
38 CD O
degrees NNS O
C NN O
) -RRB- O
. . O

List NN O
of IN O
Abbreviations NNS O

They PRP O
could MD O
act VB O
as IN O
a DT O
hinge NN O
for IN O
a DT O
possible JJ O
conformational JJ O
change NN O
. . O

Interestingly RB O
, , O
watering NN O
of IN O
the DT O
lianas NNS O
after IN O
non JJ O
- HYPH O
irrigation NN O
seemed VBD O
to TO O
lead VB O
preferentially RB O
to IN O
water NN O
shifting VBG O
to IN O
the DT O
top NN O
of IN O
the DT O
plant NN O
, , O
because IN O
, , O
after IN O
3 CD O
d NN O
of IN O
irrigation NN O
, , O
turgor NN O
pressure NN O
regeneration NN O
during IN O
the DT O
afternoon NN O
was VBD O
very RB O
fast JJ O
again RB O
at IN O
10 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
4F CD O
) -RRB- O
, , O
but CC O
not RB O
at IN O
5 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
4E CD O
) -RRB- O
. . O

The DT O
C283T NNP O
transition NN O
generates VBZ O
a DT O
novel JJ O
stop NN O
codon NN O
in IN O
exon NN O
1 CD O
of IN O
CHEK2 NNP O
, , O
leading VBG O
to IN O
truncation NN O
of IN O
the DT O
Chk2 NNP O
protein NN O
. . O

( -LRB- O
1978 CD O
) -RRB- O
Proc NNP O
. . O

AGT NNP O
participated VBD O
in IN O
the DT O
bacterial JJ O
work NN O
and CC O
drafting NN O
of IN O
the DT O
manuscript NN O
. . O

Rap1p NN O
is VBZ O
an DT O
abundant JJ O
sequence NN O
- HYPH O
specific JJ O
DNA NN O
- HYPH O
binding VBG O
protein NN O
( : O
12 CD O
) -RRB- O
. . O

The DT O
LexA NNP O
- HYPH O
RAP1 NNP O
fusion NN O
genes NNS O
were VBD O
carried VBN O
on IN O
2 CD O
micro NN O
m NN O
based VBN O
plasmids NNS O
marked VBN O
by IN O
LEU2 NNP O
( -LRB- O
designated VBN O
L1 NNP O
- HYPH O
L6 NNP O
, , O
Fig NNP O
. . O
5A NNP O
) -RRB- O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
characterize VB O
thumb NN O
motor NN O
dysfunction NN O
resulting VBG O
from IN O
simulated VBN O
lower JJR O
median JJ O
nerve NN O
lesions NNS O
at IN O
the DT O
wrist NN O
. . O

LOH NNP O
was VBD O
evaluated VBN O
by IN O
comparing VBG O
the DT O
allele JJ O
peak NN O
- HYPH O
height NN O
ratios NNS O
from IN O
blood NN O
DNA NN O
and CC O
tumor NN O
DNA NN O
. . O

Bacteria NNS O
were VBD O
pelleted VBN O
by IN O
centrifugation NN O
, , O
washed VBN O
and CC O
re NN O
- HYPH O
suspended VBN O
in IN O
sterile JJ O
1 CD O
x NN O
phosphate NN O
- HYPH O
buffered VBN O
saline NN O
( , O
PBS NNP O
, , O
pH NN O
7 CD O
. . O
4 CD O
) -RRB- O
to TO O
obtain VB O
the DT O
desired VBN O
CFU NN O
/ SYM O
ml NNP O
. . O

An DT O
aliquote NN O
of IN O
the DT O
cell NN O
lysate NN O
was VBD O
harvested VBN O
for IN O
subsequent JJ O
Chk2 NNP O
- HYPH O
mutant JJ O
- HYPH O
V5 NNP O
transfection NN O
verification NN O
. . O

54 CD O
8 CD O
7 CD O
771 CD O
? . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
on IN O
DNA NN O
electroporation NN O
into IN O
potato NN B-Species
mitochondria NN O
. . O

Since IN O
enzymatically RB O
active JJ O
Chk2 NNP O
exists VBZ O
as IN O
dimers NNS O
, , O
it PRP O
was VBD O
important JJ O
to TO O
determine VB O
the DT O
effect NN O
of IN O
Chk2 NNP O
mutants NNS O
on IN O
wild JJ O
- HYPH O
type NN O
/ SYM O
mutant JJ O
heterodimer NN O
kinase NN O
activity NN O
. . O

For IN O
anthracycline NN O
therapy NN O
in IN O
breast NN O
cancer NN O
, , O
topoisomerase NN O
- HYPH O
II NN O
amplifications NNS O
have VBP O
been VBN O
associated VBN O
with IN O
a DT O
dose NN O
- HYPH O
responsiveness NN O
different JJ O
from IN O
what WP O
is VBZ O
observed VBN O
in IN O
non NN O
- HYPH O
amplified VBN O
tumors NNS O
4 CD O
, , O
5 CD O
. . O

Finally RB O
, , O
the DT O
other JJ O
two CD O
cell NN O
lines NNS O
( , O
LAN NNP O
- HYPH O
1 CD O
and CC O
IGR NNP O
- HYPH O
NB8 NNP O
) -RRB- O
displayed VBD O
highly RB O
variable JJ O
genetic JJ O
heterogeneity NN O
from IN O
one CD O
cell NN O
to IN O
the DT O
next JJ O
( , O
Table NNP O
3 CD O
) -RRB- O
. . O

A DT O
similar JJ O
effect NN O
has VBZ O
been VBN O
reported VBN O
already RB O
for IN O
p53 NN O
beta NN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

Seven CD O
of IN O
the DT O
eight CD O
RPG NNP O
- HYPH O
UASs NNS O
that WDT O
had VBD O
barrier NN O
activity NN O
, , O
contained VBD O
a DT O
single JJ O
or CC O
a DT O
pair NN O
of IN O
tandem NN O
Rap1p NNP O
- HYPH O
binding VBG O
sites NNS O
( : O
Fig NNP O
. . O
1 CD O
, , O
strains NNS O
3 CD O
- SYM O
9 CD O
) -RRB- O
. . O

Sedimentation NN O
equilibrium NN O
data NNS O
indicated VBD O
that IN O
E NN B-Species
. . I-Species
coli NN I-Species
RdgC NNP O
exists VBZ O
in IN O
solution NN O
as IN O
a DT O
mixture NN O
of IN O
oligomeric JJ O
states NNS O
in IN O
equilibrium NN O
, , O
most RBS O
likely JJ O
monomers NNS O
, , O
dimers NNS O
and CC O
tetramers NNS O
( , O
1 CD O
) -RRB- O
. . O

( : O
15 CD O
) NFP O
that DT O
encodes VBZ O
the DT O
p53 NN O
beta NN O
isoform NN O
characterized VBN O
by IN O
Bourdon NNP O
et FW O
al NNP O
. . O

Several JJ O
rounds NNS O
of IN O
model NN O
building NN O
, , O
simulated VBN O
annealing NN O
, , O
positional JJ O
refinement NN O
and CC O
individual JJ O
B NN O
- HYPH O
factor NN O
refinement NN O
were VBD O
performed VBN O
. . O

the DT O
inserted VBN O
helical JJ O
duplex JJ O
DNA NN O
fragment NN O
such JJ O
that IN O
one CD O
DNA NN O
strand NN O
was VBD O
displaced VBN O
( : O
Figure NN O
1 CD O
) -RRB- O
. . O

G NN O
- HYPH O
quadruplex NN O
motifs NNS O
in IN O
the DT O
RNA NNP O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
significant JJ O
roles NNS O
in IN O
mRNA NNP O
turnover NN O
( : O
1 CD O
) -RRB- O
, , O
FMRP NNP O
binding NN O
( : O
22 CD O
) -RRB- O
, , O
translation NN O
initiation NN O
( SYM O
23 CD O
) -RRB- O
as RB O
well RB O
as IN O
repression NN O
( SYM O
24 CD O
) -RRB- O
. . O

The DT O
best JJS O
rankings NNS O
were VBD O
assigned VBN O
for IN O
the DT O
lowest JJS O
mean JJ O
scores NNS O
and CC O
the DT O
largest JJS O
number NN O
of IN O
the DT O
sample NN O
using VBG O
a DT O
resource NN O
. . O

Lorian NNP O
V NNP O
: : O
Effects NNS O
of IN O
subminimum JJ O
inhibitory JJ O
concentrations NNS O
of IN O
antibiotics NNS O
on IN O
bacteria NNS O
. . O

Bacterial JJ O
suspensions NNS O
were VBD O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
for IN O
45 CD O
minutes NNS O
supplemented VBN O
with IN O
2 CD O
% NN O
mouse NN B-Species
serum NN O
from IN O
Sigma NNP O
- HYPH O
Aldrich NNP O
( : O
St NNP O
. . O
Louis NNP O
, , O
MO NNP O
. . O
) -RRB- O
, , O
heat NN O
inactivated VBN O
mouse NN B-Species
serum NN O
( , O
56 CD O
degrees NNS O
C NN O
30 CD O
minutes NNS O
) -RRB- O
, , O
or CC O
bacteria NNS O
alone RB O
and CC O
then RB O
added VBN O
at IN O
an DT O
MOI NNP O
of IN O
10 CD O
: : O
1 CD O
to IN O
J774A NN O
. . O
1 CD O
cells NNS O
in IN O
triplicate NN O
. . O

Despite IN O
the DT O
wide JJ O
range NN O
of IN O
known VBN O
Chk2 NNP O
substrates NNS O
relevant JJ O
for IN O
DNA NN O
repair NN O
and CC O
cell NN O
cycle NN O
control NN O
, , O
our PRP$ O
present JJ O
findings NNS O
that IN O
CHEK2 NNP O
mutations NNS O
leading VBG O
to IN O
non JJ O
- HYPH O
functional JJ O
Chk2 NNP O
protein NN O
may MD O
substitute VB O
for IN O
p53 NN O
mutations NNS O
strongly RB O
advocate VBP O
a DT O
role NN O
for IN O
Chk2 NNP O
with IN O
respect NN O
to IN O
drug NN O
sensitivity NN O
executed VBN O
through IN O
p53 NN O
activation NN O
. . O

Both DT O
factors NNS O
had VBD O
significant JJ O
heritability NN O
; : O
however RB O
, , O
only RB O
Factor NNP O
1 CD O
, , O
loading VBG O
heavily RB O
on IN O
the DT O
MX2 NNP O
gene NN O
, , O
localized VBN O
to IN O
the DT O
4q28 CD O
. . O
2 CD O
- HYPH O
q31 CD O
. . O
1 CD O
region NN O
( -LRB- O
Table NNP O
1 CD O
) -RRB- O
, , O
and CC O
the DT O
magnitude NN O
of IN O
the DT O
LOD NNP O
score NN O
was VBD O
lower JJR O
than IN O
that DT O
of IN O
the DT O
univariate NN O
MX2 NNP O
gene NN O
transcript NN O
analysis NN O
( , O
LOD NNP O
= SYM O
2 CD O
. . O
28 CD O
) -RRB- O
. . O

For IN O
transcripts NNS O
with IN O
co NN O
- HYPH O
localized VBN O
QTLs NNS O
, , O
we PRP O
performed VBD O
bivariate NN O
linkage NN O
analysis NN O
to TO O
identify VB O
shared VBN O
genetic JJ O
effects NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
aimed VBD O
to TO O
compare VB O
age NN O
- HYPH O
specific JJ O
cortical JJ O
, , O
nuclear JJ O
and CC O
posterior JJ O
subcapsular NN O
( , O
PSC NNP O
) -RRB- O
cataract NN O
prevalence NN O
in IN O
two CD O
surveys NNS O
6 CD O
years NNS O
apart RB O
. . O

To TO O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
HK NNP O
vaccination NN O
can MD O
afford VB O
partial JJ O
protection NN O
to IN O
an DT O
otherwise RB O
lethal JJ O
challenge NN O
of IN O
B NN B-Species
. . I-Species
mallei NN I-Species
by IN O
the DT O
i NN O
. . O
p UH O
. . O
route NN O
. . O

The DT O
inside JJ O
surface NN O
around IN O
the DT O
central JJ O
hole NN O
is VBZ O
rich JJ O
in IN O
conserved JJ O
, , O
positively RB O
charged VBN O
residues NNS O
, , O
which WDT O
are VBP O
implicated VBN O
in IN O
DNA NN O
- HYPH O
binding NN O
by IN O
mutagenesis NN O
. . O

Exceptions NNS O
were VBD O
the DT O
UASs NNP O
of IN O
RPS24B NNP O
, , O
RPS28A NNP O
and CC O
RPL15A NNP O
( SYM O
13 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
puzzling JJ O
that IN O
a DT O
protein NN O
that WDT O
helps VBZ O
establish VB O
silent JJ O
chromatin NN O
could MD O
also RB O
act VB O
as IN O
a DT O
barrier NN O
to IN O
its PRP$ O
propagation NN O
. . O

Twenty CD O
- HYPH O
four CD O
hours NNS O
after IN O
plating VBG O
, , O
the DT O
medium NN O
was VBD O
replaced VBN O
with IN O
DMEM NNP O
medium NN O
containing VBG O
0 CD O
. . O
5 CD O
% NN O
FBS NN O
and CC O
1 CD O
% NN O
penicillin NN O
streptomycin NN O
with IN O
NGF NNP O
( : O
2 CD O
. . O
5 CD O
ng CD O
/ SYM O
ml NN O
) -RRB- O
with IN O
or CC O
without IN O
several JJ O
drugs NNS O
. . O

Further JJ O
increases NNS O
in IN O
cataract NN O
surgery NN O
performance NN O
would MD O
be VB O
expected VBN O
as IN O
a DT O
result NN O
of IN O
improved VBN O
surgical JJ O
skills NNS O
and CC O
technique NN O
, , O
together RB O
with IN O
extending VBG O
cataract NN O
surgical JJ O
benefits NNS O
to IN O
a DT O
greater JJR O
number NN O
of IN O
older JJR O
people NNS B-Species
and CC O
an DT O
increased VBN O
number NN O
of IN O
persons NNS B-Species
with IN O
surgery NN O
performed VBN O
on IN O
both DT O
eyes NNS O
. . O

Gels NNS O
were VBD O
run VBN O
at IN O
40 CD O
mA NN O
for IN O
1 CD O
h NNS O
in IN O
0 CD O
. . O
5 CD O
x SYM O
TBE NN O
buffer NN O
. . O

The DT O
TP53 NNP O
mutations NNS O
identified VBN O
in IN O
the DT O
tumors NNS O
of IN O
the DT O
patients NNS B-Species
treated VBN O
with IN O
epirubicin NN O
together RB O
with IN O
the DT O
clinical JJ O
response NN O
to IN O
therapy NN O
and CC O
follow NN O
- HYPH O
up NN O
data NNS O
are VBP O
presented VBN O
in IN O
Table NNP O
2 CD O
. . O

( : O
22 CD O
) , O
reported VBD O
the DT O
putative JJ O
occurrence NN O
of IN O
beta NN O
and CC O
gamma NN O
isoforms NNS O
from IN O
different JJ O
tissues NNS O
due IN O
to IN O
alternate JJ O
splicing NN O
that WDT O
indicates VBZ O
the DT O
similarity NN O
to IN O
those DT O
of IN O
p73 NN O
and CC O
p63 NN O
as IN O
identified VBN O
previously RB O
by IN O
Daniel NNP O
Caput NNP O
and CC O
co NN O
- HYPH O
workers NNS O
( SYM O
29 CD O
) -RRB- O
. . O

Previously RB O
, , O
five CD O
C NNP O
residues NNS O
, , O
two CD O
in IN O
exon NN O
1 CD O
, , O
one CD O
in IN O
the DT O
intron NN O
and CC O
two CD O
in IN O
exon NN O
2 CD O
have VBP O
been VBN O
reported VBN O
to TO O
be VB O
changed VBN O
to IN O
U NNP O
by IN O
editing VBG O
in IN O
potato NN B-Species
mitochondria NN O
( SYM O
23 CD O
) -RRB- O
. . O

A DT O
novel JJ O
, , O
non RB O
- HYPH O
invasive JJ O
, , O
online RB O
- HYPH O
monitoring NN O
, , O
versatile JJ O
and CC O
easy JJ O
plant NN O
- HYPH O
based VBN O
probe NN O
for IN O
measuring VBG O
leaf NN O
water NN O
status NN O

demonstrated VBN O
for IN O
the DT O
introns NNS O
in IN O
ovalbumin NN O
and CC O
globin NN O
( SYM O
41 CD O
, , O
42 CD O
) -RRB- O
, , O
much RB O
larger JJR O
precursor NN O
a2 CD O
mRNAs NNS O
may MD O
exist VB O
than IN O
those DT O
reported VBN O
to IN O
date NN O
. . O

Background NN O

The DT O
use NN O
of IN O
computers NNS O
and CC O
PDAs NNS O
remains VBZ O
limited JJ O
and CC O
also RB O
matches VBZ O
preferences NNS O
and CC O
resource NN O
ratings NNS O
. . O

At IN O
times NNS O
, , O
QGRS NNP O
Mapper NNP O
must MD O
analyze VB O
a DT O
considerable JJ O
amount NN O
of IN O
data NNS O
. . O

The DT O
pcDNA3 NNP O
- HYPH O
Delta NNP O
Np73 NNP O
alpha NN O
expression NN O
plasmid NN O
was VBD O
a DT O
gift NN O
of IN O
Dr NNP O
Daniel NNP O
Caput NNP O
( : O
SANOFI NNP O
, , O
Lab NNP O
e FW O
ges FW O
, , O
France NNP O
) -RRB- O
. . O

Re IN O
- HYPH O
operation NN O
for IN O
reduction NN O
of IN O
the DT O
incarcerated JJ O
bowel NN O
and CC O
tube NN O
duodenostomy NN O
with IN O
peritoneal JJ O
drainage NN O
were VBD O
required VBN O
to TO O
manage VB O
this DT O
complication NN O
. . O

For IN O
sensor NN O
calibration NN O
and CC O
data NNS O
recording VBG O
the DT O
SENBIT NNP O
software NN O
( -LRB- O
teleBITcom NN O
gmbh NN O
, , O
Teltow NNP O
, , O
Germany NNP O
) -RRB- O
was VBD O
used VBN O
. . O

Design NN O
and CC O
implementation NN O

However RB O
, , O
temperatures NNS O
at IN O
the DT O
top NN O
of IN O
the DT O
plant NN O
did VBD O
not RB O
exceed VB O
35 CD O
degrees NNS O
C NN O
and CC O
r VB O
. . O
h UH O
. . O
did VBD O
not RB O
drop VB O
below IN O
40 CD O
% NN O
. . O

These DT O
newly RB O
identified VBN O
barrier NN O
elements NNS O
together RB O
with IN O
previously RB O
described VBN O
barrier NN O
elements NNS O
( , O
STARs NNPS O
, , O
HMR NNP O
- HYPH O
tRNA NNP O
gene NN O
, , O
TEF2 NNP O
- HYPH O
UAS NNP O
and CC O
CHA1 NNP O
- HYPH O
UAS NNP O
) -RRB- O
( , O
9 CD O
- SYM O
11 CD O
, , O
21 CD O
) -RRB- O
are VBP O
scattered VBN O
across IN O
the DT O
yeast NN B-Species
genome NN O
and CC O
may MD O
play VB O
a DT O
role NN O
in IN O
dividing VBG O
the DT O
genome NN O
into IN O
functional JJ O
domains NNS O
. . O

Our PRP$ O
structure NN O
unequivocally RB O
rules VBZ O
out RP O
the DT O
monomer NN O
- HYPH O
trimer NN O
model NN O
, , O
which WDT O
fits VBZ O
the DT O
sedimentation NN O
equilibrium NN O
data NNS O
approximately RB O
, , O
as RB O
well RB O
as IN O
the DT O
monomer NN O
- HYPH O
dimer NN O
- HYPH O
tetramer NN O
model NN O
( , O
1 CD O
) -RRB- O
. . O

The DT O
authors NNS O
gratefully RB O
acknowledge VBP O
the DT O
advice NN O
, , O
laboratory NN O
assistance NN O
, , O
and CC O
careful JJ O
review NN O
of IN O
this DT O
manuscript NN O
by IN O
Dr NNP O
. . O
Robert NNP O
C NNP O
. . O
Moellering NNP O
, , O
Jr NNP O
. . O

Port NN O
- HYPH O
site NN O
herniation NN O
is VBZ O
a DT O
potentially RB O
dangerous JJ O
complication NN O
after IN O
laparoscopic JJ O
procedures NNS O
. . O

Cardiac JJ O
catheterization NN O
demonstrated VBD O
marked JJ O
mitral JJ O
valve NN O
prolapse NN O
with IN O
mitral JJ O
regurgitation NN O
. . O

Simultaneously RB O
, , O
the DT O
Pp NN O
values NNS O
were VBD O
recorded VBN O
at IN O
6 CD O
m NN O
and CC O
10 CD O
m NN O
height NN O
( , O
Fig NNP O
. . O
5B NN O
, , O
C NNP O
) -RRB- O
. . O

Of IN O
the DT O
23 CD O
mutations NNS O
detected VBN O
, , O
20 CD O
were VBD O
missense JJ O
and CC O
3 CD O
were VBD O
nonsense NN O
. . O

Glover NNP O
, , O
D NNP O
. . O

Those DT O
who WP O
had VBD O
never RB O
used VBN O
a DT O
PDA NNP O
for IN O
drug NN O
information NN O
were VBD O
instructed VBN O
to TO O
complete VB O
the DT O
computer NN O
version NN O
of IN O
the DT O
survey NN O
. . O

Both DT O
cell NN O
lines NNS O
show VBP O
reduced VBN O
transcription NN O
of IN O
VEGF NNP O
, , O
PDGFA NNP O
, , O
PDGFB NNP O
, , O
and CC O
MAP2K1 NNP O
( -LRB- O
MEK1 NNP O
) -RRB- O
after IN O
MUC1 NNP O
siRNA NNP O
. . O

Moreover RB O
, , O
major JJ O
differences NNS O
exist VBP O
in IN O
antimicrobial JJ O
susceptibility NN O
and CC O
resistance NN O
to IN O
penicillin NN O
- HYPH O
aminoglycoside NN O
synergism NN O
between IN O
these DT O
two CD O
enterococcal JJ O
species NNS O
. . O

required VBN O
for IN O
coding VBG O
the DT O
interspersed JJ O
3 CD O
kb NN O
of IN O
a2 CD O
collagen NN O
genetic JJ O
information NN O
was VBD O
5 CD O
. . O
6 CD O
fold NN O
longer RBR O
than IN O
the DT O
corresponding JJ O
a2 CD O
mRNA NN O
coding VBG O
sequences NNS O
. . O

appropriate JJ O
for IN O
quantitative JJ O
analysis NN O
. . O

We PRP O
next RB O
examined VBD O
whether IN O
MUC1 NNP O
knockdown NN O
and CC O
its PRP$ O
associated JJ O
transcriptional JJ O
alterations NNS O
would MD O
affect VB O
overall JJ O
cellular JJ O
events NNS O
. . O

The DT O
present JJ O
study NN O
further RB O
characterizes VBZ O
this DT O
portion NN O
of IN O
the DT O
a2 NN O

conducted VBN O
utilizing VBG O
[ -LRB- O
32 CD O
P NN O
] -RRB- O
- HYPH O
labeled VBN O
fetal JJ O
sheep NN B-Species
tendon NN O
type NN O
I NN O
collagen NN O
cDNA NNP O
and CC O

Pulmonary NNP O
Branch NNP O
, , O
National NNP O
Heart NNP O
, , O
Lung NNP O
and CC O
Blood NNP O
Institute NNP O
, , O
National NNP O
Institutes NNPS O
of IN O
Health NNP O
, , O
Bethesda NNP O
, , O
MD NNP O
20205 CD O
, , O
USA NNP O

Infrequently RB O
, , O
all DT O
introns NNS O

In IN O
contrast NN O
, , O
introns NNS O
9 CD O
through IN O
17 CD O
varied VBD O
over IN O
a DT O
4 CD O
. . O
5 CD O
- HYPH O
fold NN O
range NN O
. . O

L NNP O
. . O
, , O
and CC O
Chambon NNP O
, , O
P NN O
. . O

J NNP O
Clin NNP O
Invest NNP O
50 CD O
: : O
2580 CD O
- HYPH O
2584 CD O
, , O
1971 CD O

The DT O
low JJ O
hydration NN O
state NN O
of IN O
the DT O
plant NN O
apparently RB O
delayed VBD O
cell NN O
refilling NN O
. . O

However RB O
, , O
the DT O
interaction NN O
of IN O
two CD O
modes NNS O
of IN O
defence NN O
in IN O
tritrophic JJ O
systems NNS O
is VBZ O
largely RB O
unknown JJ O
. . O

Pre NN O
- HYPH O
fledging VBG O
survival NN O
from IN O
the DT O
egg NN O
to IN O
fledgling JJ O
stage NN O
( , O
independently RB O
of IN O
timing NN O
) -RRB- O
, , O
and CC O
recruitment NN O
, , O
also RB O
varied VBD O
significantly RB O
between IN O
territories NNS O
. . O

Current JJ O
climate NN O
emerged VBD O
as IN O
an DT O
important JJ O
driver NN O
of IN O
beta JJ O
diversity NN O
, , O
given VBN O
the DT O
strong JJ O
continental JJ O
- HYPH O
scale NN O
turnover NN O
, , O
particularly RB O
in IN O
north NN O
- HYPH O
south NN O
direction NN O
, , O
i LS O
. . O
e -RRB- O
. . O
, , O
in IN O
line NN O
with IN O
the DT O
latitudinal JJ O
climate NN O
gradient NN O
, , O
and CC O
, , O
more RBR O
directly RB O
, , O
the DT O
strong JJ O
correlation NN O
of IN O
climate NN O
with IN O
spatial JJ O
turnover NN O
at IN O
both CC O
continental JJ O
and CC O
regional JJ O
scales NNS O
. . O

Elephant NN B-Species
were VBD O
able JJ O
to TO O
select VB O
nutrient NN O
- HYPH O
rich JJ O
patches NNS O
and CC O
utilized VBN O
Colophospermum NNP B-Species
mopane NN I-Species
trees NNS O
inside IN O
these DT O
patches NNS O
more RBR O
than IN O
outside RB O
, , O
at IN O
scales NNS O
ranging VBG O
from IN O
2500 CD O
down RB O
to IN O
100 CD O
m NN O
( SYM O
2 CD O
) -RRB- O
. . O

Social JJ O
immunity NN O
in IN O
honeybees NNS B-Species
( -LRB- O
Apis NNP B-Species
mellifera NN I-Species
) -RRB- O
: : O
transcriptome NN O
analysis NN O
of IN O
varroa NN O
- HYPH O
hygienic JJ O
behaviour NN O
. . O

3 LS O
. . O

However RB O
, , O
we PRP O
lack VBP O
data NNS O
on IN O
realistic JJ O
species NNS O
- HYPH O
loss NN O
sequences NNS O
in IN O
threatened VBN O
, , O
real JJ O
- HYPH O
world NN O
food NN O
webs NNS O
to TO O
parameterize VB O
these DT O
models NNS O
. . O

Both CC O
full JJ O
and CC O
partial JJ O
( HYPH O
3P NN O
) -RRB- O
rbcL NNP O
regions NNS O
had VBD O
the DT O
power NN O
to TO O
discriminate VB O
between IN O
all DT O
species NNS O
, , O
but CC O
rbcL NNP O
- HYPH O
3P NNP O
can MD O
be VB O
sequenced VBN O
more RBR O
easily RB O
. . O

In IN O
2004 CD O
, , O
Flannagan NNP O
and CC O
coworkers NNS O
( , O
R NNP O
. . O
S NNP O
. . O
Flannagan NNP O
, , O
M NNP O
. . O
A NNP O
. . O
Valvano NNP O
, , O
and CC O
S NNP O
. . O
F NNP O
. . O
Koval NNP O
, , O
Microbiology NNP O
150 CD O
: : O
649 CD O
- HYPH O
656 CD O
, , O
2004 CD O
) -RRB- O
used VBD O
antisense JJ O
RNA NN O
and CC O
green JJ O
fluorescent NN O
protein NN O
( -LRB- O
GFP NNP O
) -RRB- O
expression NN O
to TO O
downregulate VB O
a DT O
single JJ O
Bdellovibrio NNP B-Species
motA NN O
gene NN O
and CC O
reported VBD O
slowed VBN O
release NN O
from IN O
the DT O
bdelloplast NN O
and CC O
altered VBN O
motility NN O
of IN O
the DT O
progeny NN O
. . O

1 LS O
. . O

We PRP O
have VBP O
named VBN O
this DT O
related JJ O
group NN O
of IN O
M NNP B-Species
. . I-Species
bovis NN I-Species
strains VBZ O
the DT O
African NNP O
2 CD O
( SYM O
Af2 CD O
) -RRB- O
clonal JJ O
complex NN O
of IN O
M NNP B-Species
. . I-Species
bovis NN I-Species
. . O

Our PRP$ O
findings NNS O
reveal VBP O
a DT O
unique JJ O
mechanism NN O
by IN O
which WDT O
R5 NNP O
HIV NNP B-Species
env NN O
and CC O
VSV NNP B-Species
- HYPH O
G NNP O
cooperate VBP O
to TO O
allow VB O
entry NN O
to IN O
naive JJ O
CD4 NNP O
( , O
+ CC O
) -RRB- O
T NN O
cells NNS O
, , O
providing VBG O
a DT O
tool NN O
to TO O
target VB O
naive JJ O
CD4 NN O
( , O
+ CC O
) NFP O
T NN O
cells NNS O
with IN O
R5 NNP O
HIV NNP B-Species
to TO O
study VB O
HIV NNP B-Species
coreceptor NN O
signaling NN O
and CC O
latency NN O
. . O

At IN O
coarser NN O
resolutions NNS O
, , O
simulated VBN O
data NN O
sets NNS O
recreate VBP O
many JJ O
aspects NNS O
of IN O
the DT O
observed VBN O
data NN O
; : O
however RB O
, , O
only RB O
one CD O
of IN O
the DT O
models NNS O
accurately RB O
predicts VBZ O
step NN O
length NN O
, , O
and CC O
all DT O
models NNS O
underestimate VBP O
the DT O
frequency NN O
of IN O
reversals NNS O
. . O

Previously RB O
, , O
we PRP O
identified VBD O
an DT O
NH NNP O
( , O
4 CD O
) -RRB- O
( , O
+ SYM O
) -RRB- O
transporter NN O
in IN O
the DT O
AM NNP O
fungus NN O
Glomus NNP B-Species
intraradices NN I-Species
( , O
GintAMT1 NNP O
) -RRB- O
involved VBN O
in IN O
NH NNP O
( , O
4 CD O
) NFP O
( NFP O
+ SYM O
) -RRB- O
uptake NN O
from IN O
the DT O
soil NN O
when WRB O
preset VBN O
at IN O
low JJ O
concentrations NNS O
. . O

Knowledge NN O
of IN O
dispersal NN O
is VBZ O
essential JJ O
to IN O
conservation NN O
efforts NNS O
, , O
but CC O
is VBZ O
often RB O
hampered VBN O
by IN O
our PRP$ O
inability NN O
to TO O
measure VB O
its PRP$ O
frequency NN O
and CC O
distance NN O
when WRB O
dispersal NN O
is VBZ O
infrequent JJ O
and CC O
difficult JJ O
to TO O
observe VB O
. . O

Driving VBG O
- HYPH O
ion NN O
studies NNS O
with IN O
phenamil NN O
, , O
carbonyl NN O
cyanide NN O
m NN O
- HYPH O
chlorophenylhydrazone NN O
( , O
CCCP NNP O
) -RRB- O
, , O
and CC O
different JJ O
pH NN O
and CC O
sodium NN O
conditions NNS O
indicated VBD O
that IN O
all DT O
Mot NNP O
pairs NNS O
are VBP O
proton NN O
driven VBN O
, , O
although IN O
the DT O
sequence NN O
similarities NNS O
of IN O
each DT O
Mot NNP O
pair NN O
suggests VBZ O
that IN O
some DT O
may MD O
originate VB O
from IN O
halophilic JJ O
species NNS O
. . O

Since IN O
neural JJ O
cells NNS O
express VBP O
IDE NNP O
, , O
the DT O
gE NNP O
/ SYM O
IDE NNP O
interaction NN O
was VBD O
dispensable JJ O
for IN O
VZV NNP B-Species
neurotropism NN O
. . O

Five CD O
of IN O
the DT O
substitution NN O
derivatives NNS O
showed VBD O
greatly RB O
decreased VBN O
lipase NN O
secretion NN O
, , O
accompanied VBN O
by IN O
defects NNS O
in IN O
secretin JJ O
assembly NN O
. . O

Overall RB O
, , O
this DT O
study NN O
provides VBZ O
valuable JJ O
information NN O
on IN O
the DT O
fruiting VBG O
processes NNS O
of IN O
L NNP B-Species
. . I-Species
edodes VBZ I-Species
through IN O
a DT O
combination NN O
of IN O
massive JJ O
cDNA NN O
pyrosequencing NN O
and CC O
LongSAGE NNP O
sequencing NN O
, , O
and CC O
the DT O
knowledge NN O
thereby RB O
obtained VBN O
may MD O
provide VB O
insight NN O
into IN O
the DT O
improvement NN O
of IN O
the DT O
yield NN O
of IN O
commercially RB O
grown VBN O
Shiitake NNP B-Species
mushrooms NNS I-Species
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
highly RB O
conserved VBN O
pocket NN O
in IN O
ExeA NNP O
is VBZ O
the DT O
binding VBG O
site NN O
for IN O
its PRP$ O
peptidoglycan JJ O
ligand NN O
and CC O
identify VB O
residues NNS O
critical JJ O
for IN O
this DT O
binding NN O
. . O

Plant NN O
cells NNS O
use VBP O
calcium NN O
- HYPH O
based VBN O
signalling VBG O
pathways NNS O
to TO O
transduce VB O
biotic NN O
and CC O
/ SYM O
or CC O
abiotic JJ O
stimuli NNS O
into IN O
adaptive JJ O
responses NNS O
. . O

The DT O
combined VBN O
use NN O
of IN O
stable JJ O
carbon NN O
and CC O
oxygen NN O
isotopes NNS O
in IN O
plant NN O
matter NN O
is VBZ O
a DT O
tool NN O
of IN O
growing VBG O
interest NN O
in IN O
cereal JJ O
crop NN O
management NN O
and CC O
breeding NN O
, , O
owing VBG O
to IN O
its PRP$ O
relevance NN O
for IN O
assessing VBG O
the DT O
photosynthetic JJ O
and CC O
transpirative JJ O
performance NN O
under IN O
different JJ O
growing VBG O
conditions NNS O
including VBG O
water NN O
and CC O
N NNP O
regimes NNS O
. . O

These DT O
results NNS O
mean VBP O
that IN O
VgR NNP O
is VBZ O
critical JJ O
for IN O
binding VBG O
Vg NNP O
and CC O
transporting VBG O
it PRP O
into IN O
the DT O
oocytes NNS O
of IN O
the DT O
insect NN O
ovary NN O
, , O
thus RB O
playing VBG O
an DT O
important JJ O
role NN O
in IN O
insect NN O
reproduction NN O
. . O

The DT O
isolates NNS O
were VBD O
Gram NNP O
- HYPH O
staining VBG O
- HYPH O
variable JJ O
, , O
non JJ O
- HYPH O
motile NN O
rods NNS O
and CC O
grew VBD O
only RB O
on IN O
H NNP O
( SYM O
2 CD O
) SYM O
/ SYM O
CO NN O
( SYM O
2 CD O
) -RRB- O
. . O

Scanning VBG O
electron NN O
microscopy NN O
( -LRB- O
SEM NNP O
) -RRB- O
revealed VBD O
a DT O
collapse NN O
of IN O
the DT O
oocysts NNS O
wall NN O
at IN O
both DT O
polar JJ O
ends NNS O
after IN O
pepsin NN O
treatment NN O
. . O

Pupal JJ O
parasitism NN O
was VBD O
not RB O
higher JJR O
than IN O
4 CD O
. . O
7 CD O
% NN O
in IN O
both DT O
habitats NNS O
, , O
and CC O
did VBD O
not RB O
vary VB O
with IN O
locality NN O
during IN O
each DT O
season NN O
or CC O
with IN O
host NN O
plant NN O
between IN O
each DT O
season NN O
. . O

A DT O
new JJ O
model NN O
of IN O
Epstein NNP B-Species
- HYPH I-Species
Barr NNP I-Species
virus NN I-Species
infection NN O
reveals VBZ O
an DT O
important JJ O
role NN O
for IN O
earlylytic JJ O
viral JJ O
protein NN O
expression NN O
in IN O
the DT O
development NN O
of IN O
lymphomas NNS O
. . O

Therefore RB O
, , O
the DT O
optimal JJ O
developmental JJ O
temperature NN O
for IN O
C NNP B-Species
. . I-Species
ciliata NN I-Species
was VBD O
determined VBN O
to TO O
be VB O
30 CD O
^ SYM O
0 CD O
C NN O
. . O

An DT O
agreement NN O
was VBD O
made VBN O
that IN O
the DT O
cachexia NN O
syndrome NN O
can MD O
develop VB O
progressively RB O
through IN O
various JJ O
stages NNS O
- : O
- HYPH O
precachexia NN O
to IN O
cachexia NN O
to IN O
refractory JJ O
cachexia NN O
. . O

While IN O
communities NNS O
in IN O
the DT O
former JJ O
state NN O
exhibited VBD O
noncyclic JJ O
dynamics NNS O
, , O
the DT O
majority NN O
of IN O
communities NNS O
in IN O
the DT O
latter JJ O
state NN O
exhibited VBD O
cyclic JJ O
dynamics NNS O
driven VBN O
by IN O
the DT O
interaction NN O
between IN O
another DT O
prey NN O
and CC O
the DT O
predator NN O
. . O

Apical JJ O
hydraulic JJ O
conductivity NN O
( -LRB- O
k NN O
) -RRB- O
was VBD O
estimated VBN O
from IN O
anatomical JJ O
data NNS O
. . O

Phylogenetic JJ O
analysis NN O
of IN O
the DT O
16S NNP O
rRNA NNP O
gene NN O
sequence NN O
demonstrated VBD O
that IN O
strain NN O
533 CD O
( , O
T NNP O
) -RRB- O
was VBD O
a DT O
member NN O
of IN O
the DT O
genus NN O
Flavobacterium NNP O
and CC O
exhibited VBD O
97 CD O
. . O
1 CD O
- SYM O
98 CD O
. . O
7 CD O
% NN O
16S CD O
rRNA NN O
sequence NN O
similarity NN O
with IN O
its PRP$ O
nearest JJS O
phylogenetic JJ O
neighbours NNS O
. . O

The DT O
combination NN O
of IN O
Delta NNP O
^ SYM O
1 CD O
^ SYM O
3C NNP O
and CC O
delta NN O
^ SYM O
1 CD O
^ SYM O
8O CD O
gave VBD O
a DT O
clear JJ O
advantage NN O
compared VBN O
with IN O
gas NN O
exchange NN O
measurements NNS O
, , O
as IN O
it PRP O
provides VBZ O
information NN O
on IN O
the DT O
instantaneous JJ O
and CC O
the DT O
long JJ O
- HYPH O
term NN O
plant NN O
photosynthetic JJ O
and CC O
transpirative JJ O
performance NN O
and CC O
are VBP O
less RBR O
labour NN O
intensive JJ O
than IN O
gas NN O
exchange NN O
measurements NNS O
. . O

DNA NN O
- HYPH O
DNA NN O
relatedness NN O
and CC O
physiological JJ O
and CC O
biochemical JJ O
tests NNS O
allowed VBD O
the DT O
differentiation NN O
of IN O
strain NN O
15 CD B-Species
- HYPH I-Species
Je NNP I-Species
- HYPH I-Species
17 CD I-Species
( HYPH I-Species
T NNP I-Species
) -RRB- I-Species
from IN O
the DT O
type NN O
strains NNS O
of IN O
the DT O
three CD O
known VBN O
Jiangella NNP O
species NNS O
. . O

Isolation NN O
and CC O
characterization NN O
of IN O
P1 NN O
adhesin NN O
, , O
a DT O
leg NN O
protein NN O
of IN O
the DT O
gliding VBG O
bacterium NN O
Mycoplasma NNP B-Species
pneumoniae NN I-Species
. . O

We PRP O
examined VBD O
the DT O
scaling VBG O
relationship NN O
of IN O
swim NN O
speed NN O
in IN O
free RB O
- HYPH O
ranging VBG O
diving NN O
birds NNS O
, , O
mammals NNS O
and CC O
turtles NNS O
( , O
37 CD O
species NNS O
; , O
mass JJ O
range NN O
, , O
0 CD O
* SYM O
5 CD O
- SYM O
90 CD O
, , O
0 CD O
kg NNS O
) , O
with IN O
phylogenetically RB O
informed VBN O
statistical JJ O
methods NNS O
and CC O
derived VBN O
the DT O
theoretical JJ O
prediction NN O
for IN O
the DT O
allometric JJ O
exponent NN O
under IN O
the DT O
COT NNP O
hypothesis NN O
by IN O
constructing VBG O
a DT O
biomechanical JJ O
model NN O
. . O

Using VBG O
gel NN O
filtration NN O
, , O
blue JJ O
- HYPH O
native JJ O
polyacrylamide NN O
gel NN O
electrophoresis NN O
( , O
BN NNP O
- HYPH O
PAGE NNP O
) -RRB- O
, , O
and CC O
chemical JJ O
cross NN O
- HYPH O
linking VBG O
, , O
the DT O
isolated VBN O
P1 NN O
adhesin NN O
was VBD O
shown VBN O
to TO O
form VB O
a DT O
complex NN O
with IN O
an DT O
accessory NN O
protein NN O
named VBN O
P90 NNP O
. . O

We PRP O
also RB O
assigned VBD O
the DT O
contigs NNS O
into IN O
the DT O
KEGG NNP O
pathways NNS O
. . O

Analysis NN O
of IN O
variance NN O
demonstrated VBD O
that IN O
seed NN O
size NN O
effects NNS O
were VBD O
particularly RB O
significant JJ O
early RB O
in IN O
development NN O
, , O
affecting VBG O
primary JJ O
root NN O
growth NN O
and CC O
gravitropism NN O
, , O
but CC O
also RB O
flowering VBG O
time NN O
. . O

Fungicide NN O
sensitivity NN O
and CC O
selection NN O
potential NN O
differs VBZ O
based VBN O
on IN O
the DT O
medium JJ O
and CC O
fungal JJ O
species NNS O
. . O

In IN O
another DT O
mutant NN O
a DT O
gene NN O
putatively RB O
encoding VBG O
a DT O
3 CD O
- HYPH O
hydroxyacyl NN O
- HYPH O
coenzyme NN O
A NN O
dehydrogenase NN O
( , O
paaH2 NN O
) -RRB- O
was VBD O
disrupted VBN O
by IN O
transposon NN O
insertion NN O
. . O

The DT O
reproductive JJ O
and CC O
developmental JJ O
biology NN O
of IN O
M NNP B-Species
. . I-Species
luteolus NNP I-Species
appears VBZ O
to TO O
be VB O
influenced VBN O
by IN O
a DT O
complex JJ O
interplay NN O
of IN O
maternal JJ O
clutch NN O
size NN O
and CC O
sex NN O
allocation NN O
strategies NNS O
, , O
offspring NN O
- HYPH O
offspring NN O
developmental JJ O
interactions NNS O
, , O
host NN O
defence NN O
mechanisms NNS O
and CC O
postemergence NN O
mating NN O
behaviour NN O
. . O

Quantitative JJ O
real JJ O
- HYPH O
time NN O
PCR NN O
analysis NN O
indicates VBZ O
that IN O
expression NN O
of IN O
HvOR6 NNP O
, , O
HsOR6 NNP O
, , O
HvOR14 NNP O
, , O
HsOR14 NNP O
, , O
HvOR15 NN O
and CC O
HsOR15 NNP O
is VBZ O
male NN O
biased VBN O
, , O
which WDT O
supports VBZ O
the DT O
hypothesis NN O
that IN O
they PRP O
have VBP O
a DT O
role NN O
in IN O
mediating VBG O
female JJ O
sex NN O
pheromone NN O
detection NN O
. . O

Experiments NNS O
with IN O
wild JJ O
- HYPH O
type NN O
Arabidopsis NNP B-Species
thaliana NN I-Species
were VBD O
designed VBN O
to TO O
quantify VB O
the DT O
influences NNS O
of IN O
parental JJ O
environment NN O
and CC O
seed NN O
size NN O
on IN O
growth NN O
and CC O
development NN O
in IN O
the DT O
next JJ O
generation NN O
. . O

We PRP O
combined VBD O
measurements NNS O
of IN O
gas NN O
exchange NN O
with IN O
carbon NN O
isotope NN O
discrimination NN O
using VBG O
tunable JJ O
diode NN O
laser NN O
absorption NN O
spectroscopy NN O
with IN O
a DT O
CO2 NNP O
calibration NN O
system NN O
specially RB O
designed VBN O
for IN O
a DT O
range NN O
of IN O
CO2 NNP O
and CC O
O2 NN O
concentrations NNS O
. . O

Our PRP$ O
results NNS O
highlight VBP O
the DT O
general JJ O
use NN O
of IN O
transcriptional JJ O
profiling NN O
for IN O
the DT O
identification NN O
of IN O
novel JJ O
proteins NNS O
involved VBN O
in IN O
cell NN O
death NN O
and CC O
their PRP$ O
potential JJ O
use NN O
as IN O
drug NN O
targets NNS O
. . O

Although IN O
maternal JJ O
and CC O
child NN O
mortality NN O
are VBP O
on IN O
the DT O
decline NN O
in IN O
southeast JJ O
Asia NNP O
, , O
there EX O
are VBP O
still RB O
major JJ O
disparities NNS O
, , O
and CC O
greater JJR O
equity NN O
is VBZ O
key JJ O
to TO O
achieve VB O
the DT O
Millennium NNP O
Development NNP O
Goals NNPS O
. . O

Flavobacterium NN O
sinopsychrotolerans NNS O
sp VBP O
. . O
nov UH O
. . O
, , O
isolated VBN O
from IN O
a DT O
glacier NN O
. . O

Constitutive JJ O
expression NN O
of IN O
GintAMT2 NNP O
in IN O
N NN O
- HYPH O
limiting VBG O
conditions NNS O
and CC O
transitory JJ O
induction NN O
after IN O
N NNP O
re IN O
- HYPH O
supply NN O
suggests VBZ O
a DT O
role NN O
for IN O
GintAMT2 NNP O
to TO O
retrieve VB O
NH NNP O
( , O
4 CD O
) SYM O
( : O
+ NFP O
) NFP O
leaked VBN O
out RP O
during IN O
fungal JJ O
metabolism NN O
. . O

Basic JJ O
and CC O
comprehensive JJ O
emergency NN O
obstetric JJ O
care NN O
were VBD O
identified VBN O
as IN O
key JJ O
effective JJ O
interventions NNS O
to TO O
reduce VB O
intrapartum NN O
stillbirths NNS O
. . O

Plant NN O
infestation NN O
, , O
stem NN O
borer NN O
density NN O
, , O
parasitism NN O
, , O
and CC O
parasitoid NN O
abundance NN O
were VBD O
assessed VBN O
during IN O
two CD O
years NNS O
in IN O
two CD O
host NN O
plants NNS O
, , O
Zea NNP B-Species
mays VBZ I-Species
( , I-Species
L NNP I-Species
. . I-Species
) -RRB- I-Species
( , O
Cyperales NNP O
: : O
Poaceae NNP O
) -RRB- O
and CC O
Sorghum NNP B-Species
bicolor NN I-Species
( : I-Species
L NNP I-Species
. . I-Species
) -RRB- I-Species
( , O
Cyperales NNP O
: : O
Poaceae NNP O
) -RRB- O
, , O
in IN O
cultivated VBN O
habitats NNS O
. . O

Notably RB O
, , O
the DT O
compositional JJ O
variation NN O
purely RB O
accounted VBN O
for IN O
by IN O
space NN O
was VBD O
greater JJR O
than IN O
that DT O
purely RB O
accounted VBN O
for IN O
by IN O
environment NN O
for IN O
both CC O
the DT O
turnover NN O
and CC O
the DT O
nestedness NN O
component NN O
of IN O
beta JJ O
diversity NN O
. . O

The DT O
findings NNS O
from IN O
the DT O
16S NNP O
rRNA NNP O
gene NN O
sequence NN O
analyses NNS O
were VBD O
supported VBN O
by IN O
analysis NN O
of IN O
McrA NNP O
, , O
the DT O
alpha NN O
subunit NN O
of IN O
methyl NN O
- HYPH O
coenzyme NN O
M NN O
reductase NN O
. . O

These DT O
results NNS O
led VBD O
us PRP O
to TO O
propose VB O
a DT O
model NN O
of IN O
coupling NN O
between IN O
the DT O
cryptogein NN O
signal NN O
, , O
calcium NN O
signalling NN O
and CC O
the DT O
transcriptional JJ O
response NN O
, , O
exerting VBG O
control NN O
of IN O
transcription NN O
through IN O
the DT O
coordinated VBN O
action NN O
of IN O
two CD O
decoding VBG O
modules NNS O
exerting VBG O
opposite JJ O
effects NNS O
. . O

The DT O
probability NN O
of IN O
an DT O
individual NN O
being VBG O
encapsulated VBN O
increased VBD O
with IN O
clutch NN O
size NN O
, , O
while IN O
the DT O
probability NN O
of IN O
being VBG O
killed VBN O
by IN O
a DT O
brood NN O
mate NN O
declined VBD O
with IN O
increasing VBG O
clutch NN O
size NN O
and CC O
with IN O
increasing VBG O
per IN O
capita FW O
availability NN O
of IN O
resources NNS O
. . O

Dual NNP O
Delta NNP O
^ SYM O
1 CD O
^ SYM O
3C NN O
/ SYM O
delta NN O
^ SYM O
1 CD O
^ SYM O
8O CD O
response NN O
to IN O
water NN O
and CC O
nitrogen NN O
availability NN O
and CC O
its PRP$ O
relationship NN O
with IN O
yield NN O
in IN O
field NN O
- HYPH O
grown VBN O
durum NN B-Species
wheat NN I-Species
. . O

The DT O
gp120 NN O
envelope NN O
protein NN O
of IN O
SIVmac239 NNP B-Species
contains VBZ O
a DT O
serine NN O
- HYPH O
threonine NN O
- HYPH O
rich JJ O
stretch NN O
of IN O
amino NN O
acids NNS O
at IN O
positions NNS O
128 CD O
to IN O
139 CD O
. . O

Our PRP$ O
results NNS O
document VBP O
that IN O
Taylor NNP O
' POS O
s POS O
power NN O
law NN O
was VBD O
a DT O
better JJR O
fit NN O
for IN O
the DT O
data NNS O
than IN O
the DT O
Iwao NNP O
and CC O
Nachman NNP O
models NNS O
. . O

The DT O
ciliate NN O
Parasterkiella NNP B-Species
thompsoni NNP I-Species
( , O
Foissner NNP O
, , O
1996 CD O
) -RRB- O
nov FW O
. . O
gen UH O
. . O
, , O
nov UH O
. . O
comb NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
the DT O
osmotic JJ O
signal NN O
transduction NN O
cascade NN O
is VBZ O
involved VBN O
in IN O
cell NN O
wall NN O
integrity NN O
in IN O
the DT O
phytopathogenic JJ O
ascomycete NN O
Botrytis NNP B-Species
cinerea NN I-Species
. . O

Two CD O
methane NN O
- HYPH O
producing VBG O
archaea NN O
, , O
designated VBN O
Mic5c12 NNP O
( , O
T NNP O
) -RRB- O
and CC O
Mic6c05 NNP O
( , O
T NNP O
) -RRB- O
, , O
were VBD O
isolated VBN O
from IN O
sludge NN O
deposited VBN O
in IN O
a DT O
crude JJ O
oil NN O
storage NN O
tank NN O
and CC O
a DT O
tubercle NN O
on IN O
the DT O
interior NN O
of IN O
a DT O
pipe NN O
transporting VBG O
natural JJ O
gas NN O
- HYPH O
containing VBG O
brine NN O
, , O
respectively RB O
. . O

Our PRP$ O
understanding NN O
of IN O
how WRB O
environmental JJ O
factors NNS O
influence VBP O
disease NN O
- HYPH O
conducive JJ O
or CC O
disease NN O
- HYPH O
suppressive JJ O
conditions NNS O
, , O
and CC O
how WRB O
a DT O
pathogen NN O
advantageously RB O
capitalizes VBZ O
on IN O
them PRP O
, , O
is VBZ O
quite RB O
limited JJ O
. . O

Fusarium NN B-Species
nepalense NN I-Species
was VBD O
resolved VBN O
as IN O
the DT O
sister NN O
lineage NN O
of IN O
Fusarium NNP B-Species
ussurianum NN I-Species
+ CC I-Species
Fusarium NNP I-Species
asiaticum NN I-Species
within IN O
an DT O
Asian JJ O
subclade NN O
of IN O
the DT O
FGSC NNP B-Species
. . O

An DT O
improved JJ O
understanding NN O
of IN O
the DT O
biological JJ O
processes NNS O
that WDT O
cause VBP O
neuroinflammation NN O
will MD O
help VB O
to TO O
define VB O
its PRP$ O
medical JJ O
importance NN O
and CC O
to TO O
identify VB O
the DT O
therapeutic JJ O
potential NN O
of IN O
interfering VBG O
with IN O
this DT O
reaction NN O
. . O

However RB O
, , O
a DT O
serine JJ O
- HYPH O
threonine NN O
- HYPH O
serine NN O
sequence NN O
specifically RB O
mediates VBZ O
the DT O
downregulation NN O
of IN O
BST NNP O
- HYPH O
2 CD O
from IN O
the DT O
cell NN O
surface NN O
and CC O
the DT O
optimal JJ O
relief NN O
of IN O
restricted VBN O
virion NN O
release NN O
. . O

Multilocus NNP O
Bayesian NNP O
species NNS O
tree NN O
analyses NNS O
augment VBP O
these DT O
results NNS O
and CC O
provide VBP O
evidence NN O
for IN O
a DT O
distinct JJ O
lineage NN O
within IN O
F NNP B-Species
. . I-Species
graminearum NN I-Species
predominately RB O
from IN O
the DT O
Gulf NNP O
Coast NNP O
of IN O
Louisiana NNP O
. . O

We PRP O
suggest VBP O
that IN O
insects NNS O
are VBP O
particularly RB O
amenable JJ O
to IN O
advancing VBG O
our PRP$ O
understanding NN O
of IN O
the DT O
biological JJ O
functions NNS O
of IN O
DNA NN O
methylation NN O
, , O
because IN O
insects NNS O
are VBP O
evolutionarily RB O
diverse JJ O
, , O
display VBP O
several JJ O
lineage NN O
- HYPH O
specific JJ O
losses NNS O
of IN O
DNA NN O
methylation NN O
and CC O
possess VBP O
tractable JJ O
patterns NNS O
of IN O
DNA NN O
methylation NN O
in IN O
moderately RB O
sized JJ O
genomes NNS O
. . O

We PRP O
conclude VBP O
that IN O
while IN O
constraints NNS O
on IN O
independent JJ O
breeding NN O
encourage VBP O
high JJ O
rates NNS O
of IN O
philopatry NN O
, , O
incest NN O
avoidance NN O
nonetheless RB O
drives VBZ O
high JJ O
rates NNS O
of IN O
dispersal NN O
by IN O
both DT O
sexes NNS O
. . O

Our PRP$ O
results NNS O
reveal VBP O
an DT O
essential JJ O
interaction NN O
between IN O
HIV NNP B-Species
- HYPH I-Species
1 CD I-Species
Gag NNP O
and CC O
the DT O
psi NNP O
- HYPH O
region NN O
that WDT O
may MD O
be VB O
distinct JJ O
from IN O
that DT O
which WDT O
occurs VBZ O
during IN O
the DT O
encapsidation NN O
of IN O
genomic JJ O
RNA NNP O
. . O

The DT O
developmental JJ O
time NN O
from IN O
egg NN O
hatching NN O
to IN O
adult NN O
emergence NN O
was VBD O
respectively RB O
47 CD O
. . O
6 CD O
, , O
35 CD O
. . O
0 CD O
, , O
24 CD O
. . O
1 CD O
, , O
20 CD O
. . O
0 CD O
, , O
and CC O
17 CD O
. . O
1 CD O
days NNS O
at IN O
the DT O
temperatures NNS O
of IN O
19 CD O
, , O
22 CD O
, , O
26 CD O
, , O
30 CD O
, , O
and CC O
33 CD O
^ SYM O
0 CD O
C NN O
. . O

4 LS O
. . O

Longevity NN O
of IN O
females NNS O
was VBD O
found VBN O
to TO O
be VB O
the DT O
shortest JJS O
, , O
17 CD O
. . O
7 CD O
days NNS O
at IN O
33 CD O
^ SYM O
0 CD O
C NN O
and CC O
the DT O
longest JJS O
, , O
58 CD O
. . O
9 CD O
days NNS O
at IN O
16 CD O
^ SYM O
0 CD O
C NN O
, , O
and CC O
that DT O
of IN O
males NNS O
was VBD O
the DT O
shortest JJS O
, , O
19 CD O
. . O
7 CD O
days NNS O
at IN O
33 CD O
^ SYM O
0 CD O
C NN O
and CC O
the DT O
longest JJS O
, , O
59 CD O
. . O
7 CD O
days NNS O
at IN O
16 CD O
^ SYM O
0 CD O
C NN O
. . O

We PRP O
introduce VBP O
the DT O
concept NN O
of IN O
nutrient NN O
load NN O
as IN O
the DT O
product NN O
of IN O
patch NN O
size NN O
, , O
number NN O
of IN O
patches NNS O
and CC O
local JJ O
patch NN O
nutrient NN O
concentration NN O
. . O

Here RB O
, , O
plant NN O
growth NN O
, , O
grain NN O
yield NN O
( , O
GY NNP O
) -RRB- O
and CC O
the DT O
associated VBN O
agronomic JJ O
components NNS O
, , O
carbon NN O
isotope NN O
discrimination NN O
( , O
Delta NNP O
^ -LRB- O
1 CD O
^ SYM O
3C NNP O
) -RRB- O
plus CC O
oxygen NN O
isotope NN O
composition NN O
( , O
delta NN O
^ SYM O
1 CD O
^ SYM O
8O CD O
) -RRB- O
as RB O
well RB O
as IN O
leaf NN O
and CC O
canopy NN O
gas NN O
exchange NN O
were VBD O
measured VBN O
in IN O
field NN O
- HYPH O
grown VBN O
wheat NN B-Species
subjected VBN O
to IN O
different JJ O
water NN O
and CC O
N NN O
availabilities NNS O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
mechanism NN O
of IN O
excystation NN O
of IN O
the DT O
rodent JJ O
parasites NNS O
Eimeria NNP B-Species
nieschulzi NNP I-Species
, , O
from IN O
rats NNS O
, , O
and CC O
Eimeria NNP B-Species
falciformis NNP I-Species
, , O
from IN O
mice NNS O
, , O
was VBD O
investigated VBN O
. . O

Zinc NNP O
was VBD O
readily RB O
transported VBN O
in IN O
the DT O
stem NN O
up RB O
to IN O
the DT O
rachis NN O
. . O

All DT O
signal NN O
transduction NN O
components NNS O
interfered VBD O
with IN O
the DT O
expression NN O
of IN O
melanin NN O
biosynthesis NN O
genes NNS O
in IN O
dark JJ O
and CC O
bright JJ O
, , O
suggesting VBG O
a DT O
coordinated JJ O
control NN O
of IN O
melanin NN O
biosynthesis NN O
. . O

Observations NNS O
of IN O
banded VBN O
birds NNS O
showed VBD O
only RB O
infrequent JJ O
fission NN O
of IN O
groups NNS O
or CC O
short JJ O
- HYPH O
distance NN O
dispersal NN O
( , O
mean JJ O
= SYM O
854 CD O
m NN O
) -RRB- O
, , O
but CC O
no DT O
apparent JJ O
sex NN O
- HYPH O
bias NN O
in IN O
these DT O
patterns NNS O
. . O

This DT O
inventory NN O
reveals VBZ O
that IN O
three CD O
types NNS O
of IN O
K NNP O
( HYPH O
+ CC O
) -RRB- O
uptake NN O
systems NNS O
, , O
TRK NNP O
and CC O
HAK NNP O
transporters NNS O
and CC O
ACU NN O
ATPases NNS O
, , O
are VBP O
widely RB O
present JJ O
in IN O
several JJ O
combinations NNS O
across IN O
fungal JJ O
species NNS O
. . O

In IN O
vitro FW O
, , O
RNA NNP O
aptamers NNS O
raised VBD O
against IN O
an DT O
HIV NNP B-Species
- HYPH I-Species
1 CD I-Species
Gag NNP O
protein NN O
, , O
lacking VBG O
the DT O
N NNP O
- HYPH O
terminal JJ O
myristate NN O
and CC O
the DT O
C NNP O
- HYPH O
terminal JJ O
p6 NN O
( , O
DP6 NNP O
- HYPH O
Gag NNP O
) -RRB- O
, , O
could MD O
bind VB O
to IN O
matrix NN O
protein NN O
( , O
MA NN O
) -RRB- O
, , O
nucleocapsid JJ O
protein NN O
( , O
NC NNP O
) -RRB- O
, , O
or CC O
entire JJ O
DP6 NNP O
- HYPH O
Gag NNP O
protein NN O
. . O

[ JJ O
Mechanism NNP O
of IN O
action NN O
of IN O
steroid JJ O
hormones NNS O
. . O
I PRP O
. . O
Estrogens NNS O
] VBP O

Premenopausal NN O
patients NNS O
with IN O
neither DT O
risk NN O
factor NN O
had VBD O
a DT O
very RB O
low JJ O
failure NN O
rate NN O
( ( O
2 CD O
. . O
6 CD O
% NN O
at IN O
5 CD O
years NNS O
) ) O
, , O
regardless RB O
of IN O
age NN O
. . O

Our PRP$ O
previous JJ O
studies NNS O
pertaining VBG O
to TO O
macrophage VB O
response NN O
to TO O
LPS NNP O
identified VBD O
a DT O
novel JJ O
DNA NNP B-Gene
- : I-Gene
binding NN I-Gene
domain NN I-Gene
located VBN O
from IN O
- : O
550 CD O
to TO O
- : O
487 CD O
in IN O
the DT O
human JJ B-Gene
TNF NNP I-Gene
- : I-Gene
alpha NN I-Gene
promoter NN I-Gene
that WDT O
contains VBZ O
transcriptional JJ O
activity NN O
, , O
but CC O
lacks VBZ O
any DT O
known JJ O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
- : B-Gene
binding NN I-Gene
sites NNS I-Gene
. . O

Because IN O
HLA NNP B-Gene
class NN I-Gene
II NNP I-Gene
molecules VBZ I-Gene
present JJ O
antigen NN O
to TO O
T NNP B-Gene
cell NN I-Gene
receptors NNS I-Gene
( ( O
TCRs NNP B-Gene
) ) O
, , O
we PRP O
have VBP O
searched VBN O
for IN O
a DT O
TCR NNP B-Gene
gene NN I-Gene
associated VBN O
with IN O
the DT O
production NN O
of IN O
anti JJ B-Gene
- : I-Gene
Ro NNP I-Gene
( ( I-Gene
SSA NNP I-Gene
) ) I-Gene
antibodies NNS I-Gene
. . O

New NNP O
data NNS O
on IN O
the DT O
pharmacokinetics NNS O
, , O
pharmacodynamics NNS O
, , O
and CC O
molecular JJ O
mechanisms NNS O
of IN O
action NN O
of IN O
glucocorticoids NNS O
have VBP O
suggested VBN O
alternative JJ O
approaches NNS O
in IN O
ALL NNP O
. . O

Activation NN O
of IN O
the DT O
interleukin JJ B-Gene
6 CD I-Gene
gene NN I-Gene
by IN O
Mycobacterium NNP O
tuberculosis NN O
or CC O
lipopolysaccharide NN O
is VBZ O
mediated VBN O
by IN O
nuclear JJ B-Gene
factors NNS I-Gene
NF NNP I-Gene
- : I-Gene
IL6 NN I-Gene
and CC O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
[ NNP O
published VBD O
erratum JJ O
appears VBZ O
in IN O
Proc NNP O
Natl NNP O
Acad NNP O
Sci NNP O
U NNP O
S NNP O
A NNP O
1995 CD O
Apr NNP O
11 CD O
; : O
92 CD O
( ( O
8 CD O
) ) O
: : O
3632 CD O
] NN O

Because IN O
of IN O
the DT O
efficient JJ O
binding NN O
of IN O
TG NNP B-Gene
by IN O
surrogate JJ B-Gene
receptors NNS I-Gene
on IN O
non JJ O
- : O
T NN O
cells NNS O
, , O
we PRP O
assessed VBD O
the DT O
ability NN O
of IN O
such JJ O
cells NNS O
to TO O
present VB O
TG NNP B-Gene
to TO O
T NNP O
cells NNS O
. . O

In IN O
order NN O
to TO O
elucidate VB O
possible JJ O
mechanisms NNS O
underlying VBG O
endothelial JJ O
cell NN O
activation NN O
by IN O
xenogeneic NNP O
serum NN O
, , O
we PRP O
focussed VBD O
on IN O
transcription NN B-Gene
factor NN I-Gene
NF NNP I-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
, , O
a DT O
central JJ O
regulator NN O
for IN O
the DT O
induction NN O
of IN O
different JJ O
genes NNS O
, , O
including VBG O
adhesive JJ B-Gene
molecules NNS I-Gene
and CC O
chemoattractants NNS B-Gene
. . O

In IN O
many JJ O
pathological JJ O
situations NNS O
, , O
the DT O
balance NN O
between IN O
Th1 NNP O
and CC O
Th2 NNP O
immune VBP O
responses NNS O
determines VBZ O
the DT O
outcome NN O
of IN O
diverse NN O
immunologically RB O
mediated VBD O
clinical JJ O
syndromes NNS O
including VBG O
infectious JJ O
, , O
autoimmune JJ O
, , O
and CC O
allergic JJ O
diseases NNS O
. . O

We PRP O
investigated VBD O
oligonucleotide JJ O
- : O
directed VBN O
triple JJ O
helix NN O
formation NN O
across IN O
this DT O
regulatory JJ B-Gene
sequence NN I-Gene
as IN O
a DT O
potential JJ O
tool NN O
to TO O
inhibit VB O
GM NNP B-Gene
- : I-Gene
CSF NNP I-Gene
gene NN O
transcription NN O
. . O

Because IN O
relatively RB O
little JJ O
is VBZ O
known VBN O
about IN O
these DT O
events NNS O
in IN O
nonhuman JJ O
primates NNS O
, , O
our PRP$ O
laboratory NN O
defined VBN O
optimal JJ O
conditions NNS O
, , O
reagents NNS O
, , O
and CC O
assays NNS O
for IN O
the DT O
study NN O
of IN O
signal JJ O
transduction NN O
events NNS O
in IN O
cells NNS O
from IN O
nonhuman JJ O
primates NNS O
. . O

An DT O
upstream JJ B-Gene
segment NN I-Gene
contains NNS O
tandem JJ B-Gene
dinucleotide NN I-Gene
repeats NNS I-Gene
( ( B-Gene
CT NNP I-Gene
) ) I-Gene
19 CD I-Gene
/ NN I-Gene
( ( I-Gene
CA NNP I-Gene
) ) I-Gene
16 CD I-Gene
. . O

The DT O
induction NN O
of IN O
these DT O
genes NNS O
is VBZ O
associated VBN O
with IN O
interleukin JJ B-Gene
- : I-Gene
2 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
2 CD I-Gene
) ) O
- : O
induced VBN O
T NNP O
- : O
cell NN O
proliferation NN O
. . O

Together RB O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
phosphorylation NN O
of IN O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
, , O
mediated VBN O
through IN O
both DT O
the DT O
TNF NNP B-Gene
- : I-Gene
alpha NN I-Gene
- : O
inducible JJ O
and CC O
the DT O
PP NNP B-Gene
- : I-Gene
2A CD I-Gene
- : I-Gene
opposing NN I-Gene
kinases NNS I-Gene
, , O
may MD O
serve VB O
to TO O
target VB O
I PRP B-Gene
kappa VBP I-Gene
B NNP I-Gene
alpha NN I-Gene
for IN O
proteasome JJ B-Gene
- : O
mediated VBN O
degradation NN O
. . O

In IN O
the DT O
leukemic JJ O
cells NNS O
of IN O
patients NNS O
without IN O
detectable JJ O
TAL1 NNP B-Gene
rearrangements NNS O
, , O
TAL1 NNP B-Gene
transcription NN O
occurred VBD O
in IN O
either CC O
a DT O
monoallelic NN O
( ( O
3 CD O
of IN O
7 CD O
patients NNS O
) ) O
or CC O
a DT O
biallelic JJ O
( ( O
4 CD O
of IN O
7 CD O
patients NNS O
) ) O
fashion NN O
. . O

ML NNP O
- : O
9 CD O
induced JJ O
nitroblue JJ O
tetrazolium NN O
( ( O
NBT NNP O
) ) O
- : O
reducing VBG O
activity NN O
of IN O
U937 NNP O
cell NN O
more RBR O
rapidly RB O
than IN O
VD3 NNS O
: : O
This DT O
differentiation NN O
marker NN O
was VBD O
induced VBN O
significantly RB O
after IN O
incubation NN O
with IN O
ML NNP O
- : O
9 CD O
and CC O
VD3 NNP O
for IN O
4 CD O
hours NNS O
and CC O
1 CD O
day NN O
, , O
respectively RB O
. . O

A DT O
T NNP B-Gene
cell NN I-Gene
- : I-Gene
specific JJ I-Gene
enhancer NN I-Gene
in IN O
the DT O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
locus NN I-Gene
is VBZ O
activated VBN O
cooperatively RB O
by IN O
Oct NNP B-Gene
and CC I-Gene
NFAT NNP I-Gene
elements NNS I-Gene
within IN O
a DT O
DNase NNP B-Gene
I PRP I-Gene
- : I-Gene
hypersensitive JJ I-Gene
site NN I-Gene
. . O

These DT O
results NNS O
suggest VBP O
that IN O
LPS NNP O
activation NN O
of IN O
JNK NNP B-Gene
in IN O
monocyte NN O
/ NN O
macrophage NN O
cells NNS O
is VBZ O
a DT O
CD14 NNP O
- : O
and CC O
protein VB O
tyrosine JJ O
phosphorylation NN O
- : O
dependent JJ O
event NN O
that WDT O
may MD O
mediate VB O
the DT O
early JJ O
activation NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
in IN O
regulating VBG O
LPS NNP O
- : O
triggered VBD O
gene NN O
induction NN O
. . O

However RB O
, , O
the DT O
signaling NN O
requirements NNS O
and CC O
sensitivity NN O
to TO O
protein VB O
synthesis NN O
inhibitors NNS O
differ VBP O
considerably RB O
. . O

The DT O
results NNS O
of IN O
supershift NN O
assays NNS O
using VBG O
NFATp NNP B-Gene
- : I-Gene
and CC I-Gene
NFATc NNP I-Gene
- : I-Gene
specific JJ I-Gene
antibodies NNS I-Gene
indicate VBP O
that IN O
NK NNP O
cell NN O
activation NN O
early RB O
after IN O
CD16 NNP B-Gene
ligand VBP O
binding VBG O
involves NNS O
primarily RB O
, , O
if IN O
not RB O
exclusively RB O
, , O
NFATp NNP B-Gene
, , O
and CC O
Western JJ O
blot NN O
analysis NN O
shows VBZ O
that IN O
this DT O
has VBZ O
the DT O
same JJ O
electrophoretic JJ O
mobility NN O
( ( O
approximately RB O
120 CD O
kD NNS O
) ) O
as IN O
that DT O
of IN O
T NNP O
lymphocytes NNS O
. . O

Identification NN O
of IN O
nucleotide JJ B-Gene
sequences NNS I-Gene
that WDT O
regulate VBP O
transcription NN O
of IN O
the DT O
MCF13 NNP O
murine NN O
leukemia NN O
virus NN O
long JJ B-Gene
terminal JJ I-Gene
repeat NN I-Gene
in IN O
activated JJ O
T NNP O
cells NNS O
. . O

Inhibition NN O
of IN O
the DT O
differentiation NN O
of IN O
human JJ O
myeloid NN O
cell NN O
lines NNS O
by IN O
redox NN O
changes NNS O
induced VBD O
through IN O
glutathione NN O
depletion NN O
. . O

Regions NNS O
of IN O
low JJ O
base NN O
order NN O
- : O
dependent NN O
stem NN O
- : O
loop NN O
potential NN O
in IN O
the DT O
region NN O
of IN O
the DT O
gene NN O
are VBP O
defined VBN O
. . O

The DT O
nuclear JJ B-Gene
receptor NN I-Gene
PPARgamma NNP B-Gene
- : O
bigger JJR O
than IN O
fat NN O
. . O

In IN O
agar NN O
cultures NNS O
, , O
47 CD O
. . O
10 CD O
cells NNS O
form RB O
7 CD O
- : O
and CC O
14 CD O
- : O
day NN O
colonies NNS O
in IN O
response NN O
to TO O
a DT O
cocktail NN O
of IN O
granulocyte NN B-Gene
/ NNP I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
( ( O
2 CD O
. . O
5 CD O
ng JJ O
/ NNP O
mL NN O
) ) O
, , O
interleukin JJ B-Gene
- : I-Gene
3 CD I-Gene
( ( O
1 CD O
ng RB O
/ NNP O
mL NN O
) ) O
, , O
and CC O
mouse NN O
CSF NNP B-Gene
- : I-Gene
1 CD I-Gene
( ( O
10 CD O
ng RB O
/ NNP O
mL NN O
) ) O
. . O

In IN O
addition NN O
, , O
vitamin NN O
D NNP O
- : O
resistant NN O
cell NN O
nuclear JJ O
extract NN O
contained VBD O
a DT O
protein NN O
( ( O
s NN O
) ) O
which WDT O
was VBD O
bound VBN O
specifically RB O
to TO O
the DT O
VDRE NNP B-Gene
and CC O
was VBD O
capable JJ O
of IN O
completely RB O
inhibiting VBG O
VDR NNP B-Gene
- : I-Gene
RXR NNP I-Gene
- : I-Gene
VDRE NNP I-Gene
complex JJ I-Gene
formation NN O
; : O
these DT O
effects NNS O
were VBD O
not RB O
demonstrated VBN O
with IN O
nuclear JJ O
extract NN O
from IN O
the DT O
wild JJ O
type NN O
cell NN O
line NN O
or CC O
with IN O
the DT O
post NN O
- : O
nuclear JJ O
extract NN O
of IN O
the DT O
vitamin NN O
D NNP O
- : O
resistant NN O
cell NN O
line NN O
. . O

First RB O
, , O
it PRP O
gives VBZ O
no DT O
information NN O
on IN O
memory NN O
to TO O
lytic JJ B-Gene
cycle NN I-Gene
antigens NNS I-Gene
; : O
second JJ O
, , O
it PRP O
preferentially RB O
amplifies VBZ O
the DT O
dominant JJ O
components NNS O
of IN O
latent JJ O
antigen NN O
- : O
specific JJ O
memory NN O
at IN O
the DT O
expense NN O
of IN O
key JJ O
subdominant JJ O
reactivities NNS O
. . O

Thus RB O
, , O
RFX5 NNP B-Gene
can MD O
activate VB O
transcription NN O
only RB O
in IN O
cooperation NN O
with IN O
CIITA NNP B-Gene
. . O

Deletion NN O
of IN O
the DT O
glucocorticoid JJ O
response NN O
elements NNS O
located VBN O
at IN O
ca MD B-Gene
. . I-Gene
bp VB I-Gene
- : I-Gene
850 CD I-Gene
upstream NN O
of IN O
Cp NNP B-Gene
did VBD O
not RB O
result VB O
in IN O
a DT O
significant JJ O
loss NN O
in IN O
activity NN O
. . O

The DT O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
ATc NNP I-Gene
is VBZ O
synthesized VBN O
in IN O
three CD O
prominent JJ O
isoforms NNS B-Gene
. . O

We PRP O
conclude VBP O
that IN O
contact NN O
with IN O
fibrinogen NN B-Gene
- : I-Gene
derived JJ I-Gene
proteins NNS I-Gene
may MD O
contribute VB O
to TO O
mononuclear VB O
phagocyte JJ O
activation NN O
by IN O
signaling VBG O
through IN O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
, , O
resulting VBG O
in IN O
selective JJ O
activation NN O
of IN O
transcriptional JJ B-Gene
regulatory JJ I-Gene
factors NNS I-Gene
, , O
including VBG O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
high JJ O
- : O
level NN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
production NN O
in IN O
atopic NN O
Th2 NNP O
cells NNS O
is VBZ O
associated VBN O
with IN O
selective JJ O
reduction NN O
of IN O
suppressive JJ O
NFAT1 NNP B-Gene
activity NN O
at IN O
the DT O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
P0 NNP I-Gene
element NN I-Gene
and CC O
that IN O
some DT O
patients NNS O
with IN O
this DT O
multifactorial JJ O
disease NN O
may MD O
have VB O
a DT O
putative JJ O
systemic JJ O
disorder NN O
at IN O
this DT O
level NN O
. . O

These DT O
data NNS O
indicate VBP O
specific JJ O
modulation NN O
of IN O
the DT O
CREB NNP B-Gene
/ NNP I-Gene
ATF NNP I-Gene
- : I-Gene
1 CD I-Gene
family NN I-Gene
of IN O
transcription NN B-Gene
factors NNS I-Gene
by IN O
the DT O
CD2 NNP B-Gene
signalling VBG O
pathway RB O
and CC O
suggest JJS O
CD2 NNP B-Gene
receptor NN O
modulation NN O
of IN O
CRE NNP B-Gene
- : O
mediated VBN O
transcription NN O
following VBG O
ligand NN O
engagement NN O
( ( O
e NN O
. . O
g NN O
. . O
cell NN O
- : O
to TO O
- : O
cell NN O
contact NN O
) ) O
. . O

The DT O
percentage NN O
of IN O
cells NNS O
expressing VBG O
CD40 NNP B-Gene
in IN O
T NNP O
and CC O
B NNP O
cell NN O
co SYM O
- : O
cultures NNS O
increased VBD O
from IN O
4 CD O
. . O
2 CD O
% NN O
to TO O
13 CD O
. . O
8 CD O
% NN O
after IN O
oligo JJ O
stimulation NN O
in IN O
patients NNS O
, , O
while IN O
it PRP O
increased VBD O
form NN O
4 CD O
. . O
7 CD O
% NN O
to TO O
48 CD O
. . O
6 CD O
% NN O
in IN O
healthy JJ O
controls NNS O
. . O

In IN O
vertebrates NNS O
, , O
five CD O
distinct JJ O
DNA NN B-Gene
binding VBG I-Gene
subunits NNS I-Gene
are VBP O
currently RB O
known VBN O
which WDT O
might MD O
extensively RB O
heterodimerize VB O
, , O
thereby RB O
forming VBG O
complexes NNS O
with IN O
distinct JJ O
transcriptional JJ O
activity NN O
, , O
DNA NNP O
sequence NN O
specificity NN O
, , O
and CC O
cell NN O
type NN O
- : O
and CC O
cell NN O
stage NN O
- : O
specific JJ O
distribution NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
examine VB O
the DT O
effects NNS O
of IN O
bis NN O
[ $ O
4 CD O
- : O
[ NN O
2 CD O
, , O
4 CD O
- : O
dioxo NN O
- : O
5 CD O
- : O
thiazolidinyl NN O
) ) O
methyl NN O
] NNP O
phenyl NN O
] NNP O
methane NN O
( ( O
YM NNP O
- : O
268 CD O
) ) O
, , O
a DT O
thiazolidinedione NN O
derivative NN O
, , O
on IN O
glucose JJ O
uptake NN O
, , O
adipocyte JJ O
differentiation NN O
through IN O
peroxisome NN B-Gene
proliferator NN I-Gene
- : I-Gene
activated VBN I-Gene
receptor NN I-Gene
gamma NN I-Gene
( ( O
PPARgamma NNP B-Gene
) ) O
, , O
and CC O
phosphatidylinositol VBZ B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
( ( O
PI NNP B-Gene
3 CD I-Gene
- : I-Gene
kinase NN I-Gene
) ) O
activity NN O
in IN O
cultured JJ O
cells NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
coordination NN O
of IN O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
and CC O
STAT6 NNP B-Gene
may MD O
be VB O
required VBN O
for IN O
induction NN O
of IN O
germline NN B-Gene
Cepsilon NNP O
transcription NN O
by IN O
IL NNP B-Gene
- : I-Gene
4 CD I-Gene
, , O
and CC O
that IN O
CD40 NNP B-Gene
- : O
mediated VBD O
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
activation NN O
may MD O
be VB O
important JJ O
in IN O
regulating VBG O
both DT O
enhancement NN O
of IN O
germline NN B-Gene
Cepsilon NNP O
transcription NN O
and CC O
class NN O
switching NN O
to TO O
IgE NNP B-Gene
. . O

Molecular JJ O
cloning NN O
of IN O
SLAP NNP B-Gene
- : I-Gene
130 CD I-Gene
, , O
an DT O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
- : I-Gene
associated VBN I-Gene
substrate NN I-Gene
of IN O
the DT O
T NNP B-Gene
cell NN I-Gene
antigen NN I-Gene
receptor NN I-Gene
- : I-Gene
stimulated VBN I-Gene
protein JJ I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
. . O

CD27 NNP B-Gene
/ NNP O
CD70 NNP O
interaction NN O
augments NNS O
IgE NNP B-Gene
secretion NN O
by IN O
promoting VBG O
the DT O
differentiation NN O
of IN O
memory NN O
B NNP O
cells NNS O
into IN O
plasma JJ O
cells NNS O
. . O

However RB O
, , O
while IN O
HUVECs NNP O
contained VBD O
endothelial JJ O
NOS NNP B-Gene
protein NN I-Gene
, , O
no DT O
inducible JJ O
NOS NNP B-Gene
was VBD O
detected VBN O
in IN O
either DT O
tolerant NN O
or CC O
nontolerant JJ O
cells NNS O
. . O

Studies NNS O
with IN O
20 CD O
- : O
epi NN O
analogues NNS O
pointed VBD O
out RP O
the DT O
importance NN O
of IN O
the DT O
carbon NN O
- : O
20 CD O
position NN O
and CC O
led VBD O
to TO O
the DT O
development NN O
of IN O
20 CD O
- : O
methyl NN O
derivatives NNS O
of IN O
VD NNP O
. . O

CD38 NNP B-Gene
is VBZ O
a DT O
leukocyte JJ B-Gene
differentiation NN I-Gene
antigen NN I-Gene
that WDT O
has VBZ O
been VBN O
thought VBN O
to TO O
be VB O
a DT O
phenotypic JJ O
marker NN O
of IN O
different JJ O
subpopulations NNS O
of IN O
T NNP O
- : O
and CC O
B NNP O
- : O
lymphocytes NNS O
. . O

In IN O
contrast NN O
, , O
virus JJ O
reactivation NN O
was VBD O
not RB O
observed VBN O
following VBG O
CD4 NNP B-Gene
oligomerization NN O
by IN O
antibodies NNS B-Gene
that WDT O
bind VBP O
other JJ O
epitopes NNS O
in IN O
D1 NNP B-Gene
, , O
including VBG O
the DT O
D1 NNP B-Gene
/ NNP I-Gene
CDR3 NNP I-Gene
- : I-Gene
loop NN I-Gene
. . O

Using VBG O
CD45 NNP O
- : O
or CC O
CD3 NNP O
- : O
negative JJ O
variants NNS O
of IN O
the DT O
Jurkat NNP O
leukemic JJ O
T NNP O
- : O
cell NN O
line NN O
we PRP O
show VBP O
that IN O
the DT O
different JJ O
biochemical JJ O
events NNS O
induced VBN O
by IN O
pervanadate NN O
appeared VBD O
to TO O
be VB O
dependent JJ O
on IN O
the DT O
presence NN O
at IN O
the DT O
cell NN O
surface NN O
of IN O
either DT O
CD45 NNP B-Gene
or CC O
CD3 NNP B-Gene
. . O

The DT O
efficacy NN O
of IN O
serotonin JJ O
reuptake NN O
inhibitors NNS O
( ( O
SRIs NNP O
) ) O
is VBZ O
uncertain JJ O
, , O
and CC O
response NN O
predictors NNS O
are VBP O
unavailable JJ O
. . O

Unlike IN O
the DT O
proposed VBN O
role NN O
of IN O
Cbl NNP B-Gene
as IN O
a DT O
negative JJ O
regulator NN O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
Cbl NNP B-Gene
homologue NN O
Cbl NNP B-Gene
- : I-Gene
b NN I-Gene
has VBZ O
a DT O
positive JJ O
role NN O
in IN O
T NNP O
- : O
cell NN O
signaling VBG O
, , O
most JJS O
likely JJ O
via IN O
a DT O
direct JJ O
interaction NN O
with IN O
the DT O
upstream JJ B-Gene
kinase NN I-Gene
Zap NNP B-Gene
- : I-Gene
70 CD I-Gene
. . O

Other JJ O
bacterial JJ O
toxins NNS O
, , O
tumor NN B-Gene
necrosis NN I-Gene
factor NN I-Gene
- : I-Gene
alpha NN I-Gene
( ( O
TNF NNP B-Gene
) ) O
, , O
interleukin JJ B-Gene
- : I-Gene
1 CD I-Gene
( ( O
IL NNP B-Gene
- : I-Gene
1 CD I-Gene
) ) O
, , O
T NNP B-Gene
cell NN I-Gene
mitogens NNS I-Gene
, , O
UV NNP O
light NN O
, , O
gamma NN O
rays NNS O
and CC O
oxidative JJ O
stress NN O
were VBD O
reported VBN O
to TO O
induce VB O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
. . O

The DT O
tax NN B-Gene
protein NN I-Gene
of IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
virus NN O
type NN O
1 CD O
mediates VBZ O
the DT O
transactivation NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
sis NN I-Gene
/ JJ I-Gene
platelet NN I-Gene
- : I-Gene
derived JJ I-Gene
growth NN I-Gene
factor NN I-Gene
- : I-Gene
B NN I-Gene
promoter NN I-Gene
through IN O
interactions NNS O
with IN O
the DT O
zinc NN B-Gene
finger NN I-Gene
transcription NN I-Gene
factors NNS I-Gene
Sp1 NNP B-Gene
and CC O
NGFI NNP B-Gene
- : I-Gene
A DT I-Gene
/ JJ I-Gene
Egr NNP I-Gene
- : I-Gene
1 CD I-Gene
. . O

However RB O
, , O
upon IN O
transition NN O
from IN O
a DT O
proliferating NN O
( ( O
G1 NNP O
) ) O
to TO O
a DT O
resting VBG O
state NN O
of IN O
the DT O
cell NN O
cycle NN O
the DT O
three CD O
genes NNS O
were VBD O
differently RB O
regulated VBN O
. . O

Increased VBN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
, , O
jun NN B-Gene
- : I-Gene
B NNP I-Gene
, , O
and CC O
jun SYM B-Gene
- : I-Gene
D NNP I-Gene
expression NN O
above IN O
basal NN O
levels NNS O
and CC O
increased VBD O
transcriptional JJ O
activity NN O
of IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
/ JJ I-Gene
TPA NNP I-Gene
responsive JJ I-Gene
elements NNS I-Gene
fused VBN O
to TO O
chloramphenicol VB B-Gene
acetyl JJ I-Gene
- : I-Gene
transferase NN I-Gene
vectors NNS I-Gene
were VBD O
observed VBN O
in IN O
T NNP O
cells NNS O
treated VBD O
with IN O
TPA NNP O
alone RB O
or CC O
in IN O
combination NN O
with IN O
dexamethasone NN O
. . O

Peripheral JJ O
blood NN O
eosinophils NNS O
were VBD O
isolated VBN O
by IN O
their PRP$ O
autofluoresence NN O
using VBG O
flow JJ O
cytometric JJ O
sorting NN O
. . O

Activation NN O
of IN O
T NNP O
lymphocytes NNS O
to TO O
produce VB O
cytokines NNS B-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
counterbalance NN O
of IN O
protein NN B-Gene
- : I-Gene
tyrosine NN I-Gene
kinases NNS I-Gene
and CC O
protein SYM O
- : O
tyrosine NN O
phosphatases NNS O
, , O
many JJ O
of IN O
which WDT O
have VBP O
a DT O
high JJ O
degree NN O
of IN O
substrate NN O
specificity NN O
because IN O
of IN O
physical JJ O
association NN O
with IN O
their PRP$ O
targets NNS O
. . O

Several JJ O
mutants NNS O
derived VBN O
from IN O
transformed VBN O
human JJ O
B NNP O
cell NN O
lines NNS O
are VBP O
defective JJ O
in IN O
expressing VBG O
major JJ B-Gene
histocompatibility NN I-Gene
complex NN I-Gene
( ( I-Gene
MHC NNP I-Gene
) ) I-Gene
class NN I-Gene
II NNP I-Gene
genes NNS I-Gene
. . O

Fifty NNP O
- : O
three CD O
cases NNS O
( ( O
11 CD O
AML NNP O
M4Eo NNP O
; : O
1 CD O
AML NNP O
M4 NNP O
with IN O
atypical JJ O
abnormal NN O
eosinophils NNS O
( ( O
AML NNP O
M4 NNP O
` `` O
` `` O
Eo NN O
' '' O
' POS O
) ) O
; : O
29 CD O
AML NNP O
M4 NNP O
; : O
8 CD O
AML NNP O
M5 NNP O
; : O
3 CD O
CMML NNP O
; : O
and CC O
1 CD O
AML NNP O
M2 NNP O
with IN O
eosinophilia NN O
) ) O
were VBD O
analyzed VBN O
. . O

Transcriptional JJ O
basis NN O
for IN O
hyporesponsiveness NN O
of IN O
the DT O
human JJ B-Gene
inducible JJ I-Gene
nitric JJ I-Gene
oxide IN I-Gene
synthase JJ I-Gene
gene NN I-Gene
to TO O
lipopolysaccharide VB O
/ NNP O
interferon NNP O
- : O
gamma NN O
. . O

As IN O
a DT O
result NN O
of IN O
its PRP$ O
transforming NN O
abilities NNS O
, , O
activated VBN B-Gene
Ras NNP I-Gene
is VBZ O
expressed VBN O
in IN O
a DT O
great JJ O
number NN O
of IN O
cancers NNS O
. . O

These DT O
clones NNS O
were VBD O
tested VBN O
for IN O
their PRP$ O
recognition NN O
of IN O
BCR1 NNP O
/ NNP O
25 CD O
. . O

This DT O
loss NN O
of IN O
STAT1 NNP B-Gene
was VBD O
also RB O
seen VBN O
in IN O
cells NNS O
from IN O
patients NNS O
treated VBN O
with IN O
fludarabine NN O
in IN O
vivo NN O
. . O

The DT O
gene NN O
encoding VBG O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
- : I-Gene
specific JJ I-Gene
dUTPase NN I-Gene
was VBD O
amplified VBN O
from IN O
virus NN B-Gene
DNA NN I-Gene
by IN O
PCR NNP O
. . O

Expression NN O
of IN O
the DT O
Epstein NNP B-Gene
- : I-Gene
Barr NNP I-Gene
virus NN I-Gene
( ( I-Gene
EBV NNP I-Gene
) ) I-Gene
latent NN I-Gene
membrane NN I-Gene
protein NN I-Gene
1 CD I-Gene
( ( I-Gene
LMP NNP I-Gene
- : I-Gene
1 CD I-Gene
) ) I-Gene
oncogene NN I-Gene
is VBZ O
regulated VBN O
by IN O
the DT O
EBV NNP B-Gene
nuclear JJ I-Gene
protein NN I-Gene
2 CD I-Gene
( ( I-Gene
EBNA NNP I-Gene
- : I-Gene
2 CD I-Gene
) ) I-Gene
transactivator NN I-Gene
. . O

We PRP O
find VBP O
that DT O
TCL1 NNP B-Gene
is VBZ O
expressed VBN O
in IN O
the DT O
majority NN O
of IN O
AIDS NNP O
IBLP NNP O
tumors NNS O
examined VBD O
. . O

The DT O
viral JJ B-Gene
protein NN I-Gene
Tax NNP B-Gene
induces VBZ O
the DT O
activation NN O
and CC O
nuclear JJ O
translocalization NN O
of IN O
transcription NN B-Gene
factor NN I-Gene
NF NNP B-Gene
- : I-Gene
kappaB NN I-Gene
, , O
which WDT O
is VBZ O
proposed VBN O
to TO O
play VB O
a DT O
crucial JJ O
role NN O
in IN O
the DT O
transformation NN O
of IN O
T NNP O
cells NNS O
by IN O
HTLV NNP O
- : O
I PRP O
. . O

HIV NNP O
- : O
1 CD O
activation NN O
and CC O
expression NN O
was VBD O
quantitated VBN O
by IN O
reverse JJ B-Gene
transcriptase NN I-Gene
assay NN O
. . O

Since IN O
GH NNP B-Gene
stimulates VBZ O
the DT O
development NN O
and CC O
function NN O
of IN O
granulocytes NNS O
, , O
we PRP O
investigated VBD O
the DT O
expression NN O
of IN O
GH NNP B-Gene
in IN O
granulocyte JJ O
subsets NNS O
. . O

In IN O
order NN O
to TO O
elucidate VB O
the DT O
role NN O
of IN O
NF NNP B-Gene
- : I-Gene
ATp NNP I-Gene
, , O
one CD O
of IN O
the DT O
most RBS O
prominent JJ O
members NNS O
of IN O
family NN O
of IN O
NF NNP B-Gene
- : I-Gene
AT NNP I-Gene
transcription NN I-Gene
factors NNS I-Gene
in IN O
peripheral JJ O
T NNP O
lymphocytes NNS O
, , O
in IN O
T NNP O
cell NN O
activation NN O
and CC O
differentiation NN O
we PRP O
created VBD O
NF NNP B-Gene
- : I-Gene
ATp NNP I-Gene
- : O
deficient NN O
mice NN O
by IN O
gene NN O
targeting NN O
. . O

RA NNP O
previously RB O
was VBD O
found VBN O
to TO O
inhibit VB O
granulocyte JJ B-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
- : O
- : O
and CC O
not RB O
granulocyte VB B-Gene
- : I-Gene
macrophage NN I-Gene
colony NN I-Gene
- : I-Gene
stimulating NN I-Gene
factor NN I-Gene
- : O
- : O
stimulated JJ O
proliferation NN O
of IN O
CD34 NNP O
+ NNP O
cells NNS O
. . O

In IN O
addition NN O
, , O
this DT O
technique NN O
should MD O
permit VB O
dissection NN O
of IN O
a DT O
full JJ O
range NN O
of IN O
cellular JJ O
signaling VBG O
pathways NNS O
at IN O
the DT O
protein NN O
level NN O
. . O

In IN O
HH514 NNP O
- : O
16 CD O
cells NNS O
, , O
transfection NN O
of IN O
Rta NNP B-Gene
leads VBZ O
to TO O
synthesis NN O
of IN O
ZEBRA NNP B-Gene
, , O
viral JJ O
DNA NNP O
replication NN O
, , O
and CC O
late JJ O
gene NN O
expression NN O
. . O

Tepoxalin NNP O
also RB O
inhibited VBD O
the DT O
secretion NN O
of IN O
a DT O
NF NNP B-Gene
- : I-Gene
kappa NN I-Gene
B NNP I-Gene
regulated VBD I-Gene
chemokine NN I-Gene
, , O
IL NNP B-Gene
- : I-Gene
8 CD I-Gene
, , O
a DT O
known JJ O
inducer NN O
of IN O
CD11b NNP B-Gene
/ NNP I-Gene
CD18 NNP I-Gene
expression NN O
. . O

Analyzed NNP O
DNA NNP B-Gene
sequences NNS I-Gene
included VBD O
delta NN B-Gene
and CC I-Gene
beta NN I-Gene
5 CD I-Gene
' '' I-Gene
flanking VBG I-Gene
regions NNS I-Gene
extending VBG O
from IN O
approximately RB O
- : B-Gene
500 CD I-Gene
to TO I-Gene
+ VB I-Gene
50bp CD I-Gene
( ( O
promoter NN B-Gene
regions NNS I-Gene
) ) O
, , O
truncated VBN O
delta NN O
and CC O
beta NN B-Gene
5 CD I-Gene
' '' I-Gene
flanking VBG I-Gene
regions NNS I-Gene
extending VBG O
from IN O
approximately RB O
- : B-Gene
250 CD I-Gene
to TO I-Gene
+ VB I-Gene
50 CD I-Gene
bp NN I-Gene
, , O
and CC O
chimeric JJ B-Gene
promoter NN I-Gene
constructions NNS I-Gene
, , O
which WDT O
consisted VBD O
of IN O
a DT O
distal JJ O
delta NN B-Gene
or CC I-Gene
beta NN I-Gene
fragment NN I-Gene
fused VBD O
to TO O
a DT O
proximal JJ B-Gene
beta NN I-Gene
or CC I-Gene
delta JJ I-Gene
sequence NN I-Gene
. . O

Immunohistochemical JJ O
staining NN O
demonstrated VBD O
RelB NNP B-Gene
within IN O
the DT O
differentiated JJ O
lymph NN O
node NN O
interdigitating VBG O
DC NNP O
and CC O
follicular JJ O
DC NNP O
, , O
but CC O
not RB O
undifferentiated JJ O
DC NNP O
in IN O
normal JJ O
skin NN O
. . O

Increased VBN O
expression NN O
of IN O
the DT O
c JJ B-Gene
- : I-Gene
jun NN I-Gene
protooncogene NN O
and CC O
an DT O
increase NN O
in IN O
AP NNP B-Gene
- : I-Gene
1 CD I-Gene
binding NN O
activity NN O
in IN O
PKC NNP O
- : O
zeta NN O
cells NNS O
provides VBZ O
a DT O
potential JJ O
mechanism NN O
for IN O
explaining VBG O
the DT O
altered JJ O
differentiation NN O
status NN O
of IN O
this DT O
cell NN O
. . O

Our PRP$ O
results NNS O
demonstrate VBP O
that IN O
PMLRAR NNP B-Gene
alpha VBP I-Gene
impairs NNS O
neutrophil JJ O
differentiation NN O
and CC O
initiates VBZ O
the DT O
development NN O
of IN O
APL NNP O
. . O

The DT O
protein NN O
synthesis NN O
inhibitor NN O
cycloheximide NN O
did VBD O
not RB O
block VB O
the DT O
induction NN O
of IN O
any DT O
of IN O
these DT O
genes NNS O
, , O
and CC O
in IN O
fact NN O
, , O
super JJR O
- : O
induced VBD O
the DT O
expression NN O
of IN O
c SYM B-Gene
- : I-Gene
jun NN I-Gene
and CC O
hck NN B-Gene
. . O

This DT O
RFLP NNP B-Gene
pair NN I-Gene
occurs VBZ O
in IN O
76 CD O
% NN O
of IN O
patients NNS O
with IN O
Ro NNP B-Gene
( ( I-Gene
SSA NNP I-Gene
) ) I-Gene
precipitins VBZ O
, , O
84 CD O
% NN O
of IN O
anti JJ O
- : O
Ro NNP B-Gene
( ( I-Gene
SSA NNP I-Gene
) ) I-Gene
- : O
positive JJ O
patients NNS O
lacking VBG O
La NNP B-Gene
( ( I-Gene
SSB NNP I-Gene
) ) I-Gene
precipitins VBZ B-Gene
, , O
but CC O
only RB O
41 CD O
% NN O
of IN O
the DT O
patients NNS O
lacking VBG O
both DT O
precipitins NNS B-Gene
( ( O
P NNP O
= VBZ O
0 CD O
. . O
4 CD O
) ) O
. . O

The DT O
transcriptionally RB B-Gene
regulatory JJ I-Gene
regions NNS I-Gene
of IN O
the DT O
lymphomagenic JJ O
Akv NNP O
and CC O
SL3 NNP O
- : O
3 CD O
murine NN O
leukemia NN O
retroviruses NNS O
( ( O
MLVs NNP O
) ) O
contain VBP O
two CD O
types NNS O
of IN O
E NNP B-Gene
- : I-Gene
box NN I-Gene
consensus NN I-Gene
motifs NNS I-Gene
, , O
CAGATG NNP O
. . O

Inhibition NN O
of IN O
membrane NN O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
alpha NN I-Gene
and CC O
IL NNP B-Gene
- : I-Gene
2R CD I-Gene
beta NN I-Gene
expression NN O
by IN O
10 CD O
( ( O
- : O
6 CD O
) ) O
M NNP O
DM NNP O
was VBD O
partially RB O
reversible JJ O
by IN O
recombinant JJ B-Gene
human JJ I-Gene
IL NNP I-Gene
- : I-Gene
2 CD I-Gene
( ( O
rhIL VB B-Gene
- : I-Gene
2 CD I-Gene
) ) O
. . O

Furthermore RB O
, , O
SLP NNP B-Gene
- : I-Gene
76 CD I-Gene
and CC O
Vav NNP B-Gene
have VBP O
a DT O
synergistic JJ O
effect NN O
on IN O
interleukin NN B-Gene
( ( I-Gene
IL NNP I-Gene
) ) I-Gene
- : I-Gene
2 CD I-Gene
promoter NN I-Gene
activity NN O
in IN O
T NNP O
cells NNS O
. . O

Chloramphenicol NNP B-Gene
acetyltransferase NN I-Gene
expression NN I-Gene
constructs NNS I-Gene
containing VBG O
regions NNS O
of IN O
the DT O
human JJ B-Gene
collagenase NN I-Gene
- : I-Gene
1 CD I-Gene
promoter NN I-Gene
were VBD O
stably RB O
or CC O
transiently RB O
transfected VBN O
into IN O
U937 NNP O
cells NNS O
, , O
and CC O
reporter NN O
activity NN O
was VBD O
assessed VBN O
at IN O
various JJ O
times NNS O
after IN O
the DT O
onset NN O
of IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
( ( O
PMA NNP O
) ) O
- : O
mediated VBN O
differentiation NN O
. . O

Two CD O
main JJ O
pieces NNS O
of IN O
data NNS O
prompted VBD O
us PRP O
to TO O
focus VB O
on IN O
the DT O
activation NN O
of IN O
the DT O
platelet NN B-Gene
fibrinogen NN I-Gene
receptor NN I-Gene
, , O
the DT O
alphaIIbbeta3 NN B-Gene
integrin NN I-Gene
. . O

